<SEC-DOCUMENT>0001104659-25-019842.txt : 20250303
<SEC-HEADER>0001104659-25-019842.hdr.sgml : 20250303
<ACCEPTANCE-DATETIME>20250303170327
ACCESSION NUMBER:		0001104659-25-019842
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		20
FILED AS OF DATE:		20250303
DATE AS OF CHANGE:		20250303
EFFECTIVENESS DATE:		20250303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CELESTICA INC
		CENTRAL INDEX KEY:			0001030894
		STANDARD INDUSTRIAL CLASSIFICATION:	PRINTED CIRCUIT BOARDS [3672]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				980185558
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285515
		FILM NUMBER:		25699257

	BUSINESS ADDRESS:	
		STREET 1:		5140 YONGE STREET, SUITE 1900
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M2N 6L7
		BUSINESS PHONE:		416-448-5800

	MAIL ADDRESS:	
		STREET 1:		5140 YONGE STREET, SUITE 1900
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M2N 6L7
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>tm257951d1_s3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on March 3, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registration
No. 333-</B></FONT>&#8239;&#8239;&#8239;&#8239;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CELESTICA INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ONTARIO, CANADA<BR>
</B></FONT><FONT STYLE="font-size: 10pt">(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>98-0185558<BR>
</B></FONT><FONT STYLE="font-size: 10pt">(I.R.S. Employer<BR>
Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5140 Yonge Street, Suite 1900</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Toronto, Ontario</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Canada M2N 6L7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(416) 448-5800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">including area code, of registrant's principal
executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Corporation Trust Company<BR>
Corporation Trust Center<BR>
1209 Orange Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Wilmington,
DE 19801<BR>
(302) 658-7581<BR>
</B></FONT>(Name, address, including zip code, and telephone number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ryan J. Dzierniejko, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Skadden, Arps, Slate, Meagher &amp; Flom LLP
    </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>One Manhattan West</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York, United States 10001-8602</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212) 735-3712</B></P></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Matthew Merkley, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Blake, Cassels &amp; Graydon LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>199 Bay Street, Suite 4000</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commerce Court West</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Toronto, Ontario, Canada M5L 1A9</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(416) 863-2400</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Approximate
date of commencement of proposed sale to the public:</B></FONT> From time to time after the effective date of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box. </FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering. </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. </FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of &quot;large accelerated filer,&quot; &quot;accelerated filer,&quot; &quot;smaller reporting company&quot; and &quot;emerging
growth company&quot; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Wingdings; width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Large
    accelerated filer </FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt; font-style: normal; font-weight: normal">&#120;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><FONT STYLE="font-size: 10pt">Accelerated filer
    &#9744;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Non-accelerated filer &#9744;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Smaller reporting company &#9744;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 4in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Emerging growth company &#9744;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>PROSPECTUS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm257951d1_s3asrimg001.jpg" ALT="">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Celestica Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Shares<BR>
Preferred Shares<BR>
Debt Securities<BR>
Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may offer and sell from
time to time, in one or more offerings: common shares, preferred shares, debt securities and/or warrants to purchase common shares, preferred
shares, debt securities or warrants (collectively, the &quot;securities&quot;). This prospectus may also be used by our shareholders to
offer our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus describes
some of the general terms that may apply to the securities. Each time we (or any selling shareholder) offer to sell any securities, we
will provide specific terms of such securities and the offering in a supplement to this prospectus and/or a free writing prospectus. We
may not use this prospectus to sell securities unless we also give prospective investors a supplement to this prospectus and/or a free
writing prospectus. The prospectus supplement and/or free writing prospectus may also add, update or change information contained in this
prospectus. You should read this prospectus and the applicable prospectus supplement and/or free writing prospectus carefully before you
invest in our securities. All references in this prospectus to a prospectus supplement include references to a free writing prospectus
if a free writing prospectus is filed to set forth any terms of any securities offering hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We (or any selling shareholder)
may offer the securities for sale in a number of different ways, including directly to purchasers, through one or more agents, or to or
through underwriters or dealers, or through a combination of these methods, on a delayed or continuous basis. For additional information,
you should refer to the section entitled &quot;Plan of Distribution&quot; in this prospectus. If any agents, underwriters or dealers are
involved in the sale of any of our securities, their names, and any applicable purchase price, fee, commission or discount arrangement
between or among them, will be set forth in the applicable prospectus supplement or other offering materials. Any selling shareholder
will be named in a supplement to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common shares are listed
on the New York Stock Exchange and the Toronto Stock Exchange and trade under the symbol &quot;CLS.&quot; On February 28, 2025, the last
reported sale price of the common shares on the NYSE was $107.05 per common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves risk. See the &quot;Risk Factors&quot; section on page 5 of this prospectus, in any applicable prospectus supplement, and in
any documents we incorporate by reference in this prospectus or any applicable prospectus supplement(s) before investing in our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>NEITHER
the Securities and Exchange Commission Nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is March 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Page</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_002">ABOUT THIS PROSPECTUS</A></TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_002">1</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_003">PROSPECTUS SUMMARY</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_003">2</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_004">CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_004">4</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_005">RISK FACTORS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_005">5</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_006">USE OF PROCEEDS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_006">6</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_007">DESCRIPTION OF SHARE CAPITAL</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_007">6</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_008">DESCRIPTION OF OTHER SECURITIES</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_008">9</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_009">PLAN OF DISTRIBUTION</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_009">18</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_010">MATERIAL INCOME TAX CONSIDERATIONS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_010">20</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_011">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_011">20</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_012">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_012">21</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_013">LEGAL MATTERS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_013">21</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_014">ENFORCEABILITY OF CIVIL LIABILITIES</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_014">22</A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 5pt; padding-left: 0in"><A HREF="#har_015">EXPERTS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 5pt"><A HREF="#har_015">22</A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_002"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In this prospectus, unless
otherwise noted, &quot;Celestica,&quot; the &quot;Company,&quot; &quot;we,&quot; &quot;us&quot; and &quot;our&quot; refer to Celestica
Inc. and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
an &quot;automatic shelf&quot; registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the &quot;Commission&quot;)
as a &quot;well known seasoned issuer&quot; using the &quot;shelf&quot; registration process. Under this shelf registration process, using
this prospectus, we may offer and sell, from time to time, in one or more offerings, any of the securities described in this prospectus
(and our shareholders may offer and sell our common shares). This prospectus provides a general description of the securities we may offer,
as well as other information you should know before investing in our securities. Each time we or selling shareholders sell securities
under this prospectus, we will provide a prospectus supplement and/or free writing prospectus that contains specific information about
the terms of the offering and of the securities being offered. The prospectus supplement or free writing prospectus may also add, clarify,
update or change information contained in this prospectus, and accordingly, to the extent any statement we make in that prospectus supplement
or free writing prospectus is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed
modified or superseded by those made in such prospectus supplement or free writing prospectus. No limit exists on the aggregate amount
of the securities we or selling shareholders may sell pursuant to the registration statement of which this prospectus is a part. You should
read this prospectus, any applicable prospectus supplements or free writing prospectuses, together with additional information described
below under the captions &quot;Where You Can Find More Information&quot; and &quot;Incorporation of Certain Information by Reference&quot;
below, before you decide whether to invest in our securities. <B><I>All references in this prospectus to a prospectus supplement include
references to a free writing prospectus if a free writing prospectus is filed to set forth any terms of any securities offering hereunder</I></B><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>You should rely only on
the information we provide or incorporate by reference in this prospectus or any applicable prospectus supplement. We have not authorized
anyone to provide you with different or additional information. You should not assume that the information contained in this prospectus,
any prospectus supplement, or any other document we incorporate by reference herein or therein is accurate as of any date other than the
date of such documents, regardless of the time of delivery of the prospectus, prospectus supplement, or any sale of the securities. Our
business, financial condition, results of operations and prospects, as well as other information, may have changed since such dates.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus does not contain
all of the information included in the registration statement of which it is a part. We urge you to read that registration statement in
its entirety, including all amendments, exhibits, schedules and supplements to that registration statement, which can be obtained from
the Commission as described below under the caption &quot;Where You Can Find More Information.&quot; You may also obtain the information
we incorporate by reference into this prospectus without charge by following the instructions below under the caption &quot;Incorporation
of Certain Information by Reference.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The distribution of this prospectus
may be restricted by law in certain jurisdictions. You should inform yourself about and observe any of these restrictions. We are not
(and any selling shareholders are not), making an offer to sell or soliciting an offer to buy these securities in any jurisdiction where
the offer or sale is not permitted, or where the person making the offer or solicitation is not qualified to do so, or to any person to
whom it is unlawful to make the offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In making an investment decision,
you must rely on your own examination of our Company and the terms of the offering and the securities, including the merits and risks
involved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not making any representation
to any purchaser of the securities registered hereby regarding the legality of an investment in the securities by such purchaser. You
should not consider any information in this prospectus to be legal, business or tax advice, and you should consult your own legal, business
and tax advisors for advice regarding an investment in the securities offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In this prospectus, unless
we state otherwise, all dollar amounts in this prospectus are expressed in United States (U.S.) dollars, and all references to &quot;U.S.$&quot;
or &quot;$&quot; are to U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; padding-right: 5.9pt; padding-left: 5.9pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_003"></A>PROSPECTUS SUMMARY</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section summarizes some of the information
    that is contained later in this prospectus or in other documents incorporated by reference into this prospectus. As an investor or prospective
    investor, you should review carefully the risk factors and the more detailed information appearing later in this prospectus or contained
    in the documents that we incorporate by reference into this prospectus.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Our Business</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We deliver innovative supply chain solutions globally
    to customers in two operating and reporting segments: Advanced Technology Solutions (&quot;ATS&quot;) and Connectivity and Cloud Solutions
    (&quot;CCS&quot;).</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ATS segment consists of our ATS end market,
    and is comprised of our aerospace and defense (&quot;A&amp;D&quot;), Industrial, HealthTech, and Capital Equipment businesses. Our Capital
    Equipment business is comprised of our semiconductor and display businesses. Our CCS segment consists of our Communications and Enterprise
    end markets. Our Enterprise end market is comprised of our servers and storage businesses.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our customers include original equipment manufacturers
    (&quot;OEMs&quot;), cloud-based and other service providers, including hyperscalers, and other companies in a wide range of industries.
    Our global headquarters is located in Toronto, Ontario, Canada. We operate a network of sites and centers of excellence strategically
    located in North America, Europe and Asia, with specialized end-to-end supply chain capabilities tailored to meet specific market and
    customer product lifecycle requirements.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We offer a comprehensive range of product manufacturing
    and related supply chain services to customers in both of our segments, including design and development, new product introduction, engineering
    services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision
    machining, order fulfillment, logistics, product licensing, and after-market repair and return and IT asset management and disposition
    (&quot;ITAM/ITAD&quot;) services. Our Hardware Platform Solutions (&quot;HPS&quot;) offering, within our CCS segment, includes the development
    of infrastructure platforms, hardware and software design solutions, including open-source software that complements our hardware offerings,
    and services that can be used as-is, or customized for specific applications in collaboration with our customers, and management of program
    design and aspects of the supply chain, manufacturing, and after-market support, including ITAM/ITAD.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our services and solutions create value
    for our customers by enabling their strategies, while accelerating their time-to-market, and by providing higher quality, lower cost,
    and reduced cycle times (as compared to insourcing) in our customers' supply chains. We believe this results in lower total cost of ownership,
    greater flexibility, higher returns on invested capital and improved competitive advantage for our customers in their respective markets.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Products and services
in our ATS segment are extensive and are often more regulated than in our CCS segment, and can include the following: government-certified
and highly-specialized manufacturing, electronic and enclosure-related services for A&amp;D customers; high-precision semiconductor and
display equipment and integrated subsystems; a wide range of industrial automation, controls, test and measurement devices; engineering-focused
engagements, including in the areas of telematics, human machine interface, Internet-of-Things and embedded systems; advanced solutions
for surgical instruments, diagnostic imaging and patient monitoring; and efficiency products to help manage and monitor the energy and
power industries. Products and services in our CCS segment consist predominantly of enterprise-level data communications and information
processing infrastructure products and systems, and can include routers, switches, data center interconnects, edge solutions, servers
and storage-related products used by a wide range of businesses and cloud-based and other service providers to manage digital connectivity,
commerce and social media applications. Our ATS segment businesses typically have higher margin profiles and margin volatility, higher
working capital requirements, lower volumes and longer product lifecycles than the traditional businesses in our CCS segment. Within
our CCS segment, however, our HPS business (which includes firmware/software enablement across all primary IT infrastructure data center
technologies, open-source software offerings that complement our hardware platforms, and after-market services, including ITAM/ITAD)
typically has a higher margin profile than our traditional CCS businesses, but also requires specific investments (including research
and development (&quot;R&amp;D&quot;)) and higher working capital. Our CCS segment generally experiences a high degree of volatility
in terms of revenue and product/service mix, and as a result, our CCS segment margin can fluctuate from period to period. In recent periods,
we have experienced an increasing shift in the mix of our programs towards cloud-based and other service providers, which are cyclically
different from our traditional OEM customers, creating more volatility and unpredictability in our revenue patterns, and additional challenges
with respect to the management of our supply chain and working capital requirements.&nbsp;&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; padding-right: 5.9pt; padding-left: 5.9pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We remain committed to making the investments
    we deem necessary to support our long-term growth strategy, strengthen our competitive position, enhance customer satisfaction, and increase
    long-term shareholder value. Within both of our segments, we are focused on: increased penetration in our end markets; diversifying our
    customer mix and product portfolios, including increasing design and development, engineering, and after-market services (higher value-added
    services); and diversifying our capabilities and supply chain. We intend to continue to expand our business by growing our CCS segment,
    focusing on our HPS business, high-value EMS programs (including with hyperscalers) and services, and by continuing to pursue new customers
    and acquisition opportunities in both of our segments.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Corporate Information</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were incorporated in Ontario, Canada on September
    27, 1996. We are a corporation domiciled in the Province of Ontario, Canada and operate under the Business Corporations Act (Ontario)
    (the &quot;OBCA&quot;). Our principal executive offices are located at 5140 Yonge Street, Suite 1900, Toronto, Ontario, Canada M2N 6L7.
    Our telephone number is (416) 448-5800.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to our incorporation, we were an IBM manufacturing
    unit that provided manufacturing services to IBM for more than 75 years. In 1993, we began providing electronics manufacturing services
    to non-IBM customers. In October 1996, we were purchased from IBM by an investor group led by Onex Corporation (&quot;Onex&quot;), and
    in 1998, we completed our initial public offering. In June 2023 and August 2023, Onex (our then-controlling shareholder), completed underwritten
    secondary public offerings of an aggregate of approximately 18.8 million of our Subordinate Voting Shares (now designated common shares).
    In connection with such offerings, we converted all of our outstanding multiple voting shares (&quot;MVS&quot;) into Subordinate Voting
    Shares (now designated common shares). Subsequent to the August 2023 secondary offering, we have no MVS outstanding and Onex is no longer
    our controlling shareholder.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common shares are listed on the New York Stock
    Exchange and the Toronto Stock Exchange, and trade under the symbol &quot;CLS.&quot;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Securities</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
    may use this prospectus to offer: common shares; preferred shares; debt securities (</FONT>consisting of senior or subordinated, and/or
    secured or unsecured, debentures, notes or other evidences of indebtedness); and/or warrants to purchase common shares, preferred shares,
    debt securities or other securities. This prospectus may also be used by our shareholders to offer our common shares. Our debt securities
    may be guaranteed by one or more of our subsidiaries.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A prospectus supplement will describe the specific
    types, amounts, prices, and detailed terms of any of these offered securities and may describe certain risks in addition to those described
    herein associated with an investment in the securities.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Listing</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any securities are to be listed or quoted on
    a securities exchange or quotation system, the applicable prospectus supplement will say so.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Net Proceeds</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated in an accompanying
prospectus supplement, we will use the net proceeds from our sale of any securities for general corporate purposes. We will not receive
any proceeds from the sale of our common shares by any selling shareholders.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_004"></A>CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to historical
information, this prospectus (and any prospectus supplement) and the documents we incorporate by reference in this prospectus (and in
any prospectus supplement) contain &quot;forward-looking statements&quot; within the meaning of Section 27A of the U.S. Securities Act
of 1933, as amended (the &quot;Securities Act&quot;), Section 21E of the U.S. Securities Exchange Act of 1934, as amended, (the &quot;Exchange
Act&quot;), and forward-looking information within the meaning of applicable Canadian securities laws (collectively, &quot;forward-looking
statements&quot;), including, without limitation, statements related to: our priorities, intended areas of focus, targets, objectives
and goals; trends in the electronics manufacturing services (&quot;EMS&quot;) industry and our segments (and/or their constituent businesses)
and their anticipated impact; the anticipated impact of current market conditions and customer-specific factors on each of our segments
(and/or their constituent businesses) and near term expectations; potential restructuring and divestiture actions; our anticipated financial
and/or operating results and outlook, including expected revenue increases and decreases (or remaining flat), as well as growth in certain
businesses and end markets; our strategies; our credit risk; the potential impact of acquisitions, or program wins, transfers, losses
or disengagements; materials, component and supply chain constraints; anticipated expenses, capital expenditures and other working capital
requirements and contractual obligations (and intended methods of funding such items); the potential impact of trade policies between
countries in which we conduct business (including the potential tariffs implemented by U.S. government); the impact of our price reductions
and longer payment terms; our intended repatriation of certain undistributed earnings from non-Canadian subsidiaries (and amounts we do
not intend to repatriate in the foreseeable future); the potential impact of tax and litigation outcomes; investor dissatisfaction with
inclusion, employee engagement, and other environmental, social and governance (&quot;ESG&quot;) matters; our intention to settle employee
share unit awards in common shares (&quot;Common Shares&quot;); our ability to use certain tax losses; intended investments in our business;
the potential impact of the pace of technological changes, customer outsourcing, program transfers, and the global economic environment;
the intended method of funding Common Share repurchases; the impact of our outstanding indebtedness; liquidity and the sufficiency of
our capital resources; our intention to settle outstanding equity awards with Common Shares; our financial statement estimates and assumptions;
recently-issued accounting pronouncements and amendments; the potential adverse impacts of events outside of our control; mandatory prepayments
under our credit facility; pension plan funding requirements and obligations, and the impact of annuity purchases; our compliance with
covenants under our credit facility; refinancing debt at maturity; interest rates and expense; income tax incentives; accounts payable
cash flow levels; accounts receivable sales; expectations with respect to reporting units with goodwill; our future warranty obligations;
cybersecurity threats and incidents; our intentions with respect to environmental assessments for newly-leased or acquired properties;
our expectations with respect to expiring leases; our intention to retain earnings for general corporate purposes; costs in connection
with our pursuit of acquisitions and strategic transactions; and expectations regarding the acceptance of offers to sell accounts receivable
(&quot;A/R&quot;) under our A/R sales programs and supplier financing programs. Also, documents which we subsequently file with the Commission
and are incorporated herein by reference will contain such forward-looking statements. Forward-looking statements may, without limitation,
be preceded by, followed by, or include words such as &quot;believes,&quot; &quot;expects,&quot; &quot;anticipates,&quot; &quot;estimates,&quot;
 &quot;intends,&quot; &quot;plans,&quot; &quot;continues,&quot; &quot;project,&quot; &quot;target,&quot; &quot;objective,&quot; &quot;goal,&quot;
 &quot;potential,&quot; &quot;possible,&quot; &quot;contemplate,&quot; &quot;seek,&quot; or similar expressions, or may employ such future
or conditional verbs as &quot;may,&quot; &quot;might,&quot; &quot;will,&quot; &quot;could,&quot; &quot;should&quot; or &quot;would,&quot;
or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. In addition, any statements
concerning future financial performance, ongoing business strategies or prospects, and possible future actions, which may be provided,
are also forward-looking statements. For forward-looking statements, we claim the protection of the safe harbor for forward-looking statements
contained in the U.S. Private Securities Litigation Reform Act of 1995, and for forward-looking information under applicable Canadian
securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward-looking statements
contained in this prospectus (and any prospectus supplement) and the documents we incorporate by reference in this prospectus (and in
any prospectus supplement) are based on various assumptions, many of which involve factors that are beyond our control. Our material assumptions
include: growth in manufacturing outsourcing from customers in diversified markets; our ability to retain programs and customers, including
no unexpected customer or program transfers, losses or disengagements; no unforeseen adverse changes in our mix of businesses; no undue
negative impact on our customers' ability to compete and succeed using products we manufacture and services we provide; continued growth
in our end markets; our ability to successfully diversify our customer base and develop new capabilities; anticipated demand levels across
our businesses; continued growth in the advancement and commercialization of artificial intelligence (&quot;AI&quot;) technologies and
cloud computing; supporting sustained high levels of capital expenditure investments by leading hyperscaler, AI and data center customers;
no significant unforeseen negative impacts to our operations; no unforeseen materials price increases, margin pressures, or other competitive
factors affecting the EMS or original design manufacturer industries in general or our segments in particular; compliance by third parties
with their contractual obligations; that our customers will retain liability for product/component tariffs and countermeasures; our ability
to keep pace with rapidly changing technological developments; the successful resolution of quality issues that arise from time to time;
fluctuation of production schedules from our customers in terms of volume and mix of products or services; the timing and execution of,
and investments associated with, ramping new business; supplier performance and quality, pricing and terms; the costs and availability
of components, materials, services, equipment, labor, energy and transportation; no significant decline in the global economy or in economic
activity in our end markets due to a major recession or otherwise; no unforeseen disruptions due to geopolitical factors (including war)
causing significant negative impacts to economic activity, global or regional supply chains or normal business operations; that global
inflation will not have a material impact on our revenues or expenses; the impact of anticipated market conditions on our businesses;
the stability of currency exchange rates; the availability of capital resources for, and the permissibility under our credit facility
of, repurchases of outstanding Common Shares under our current normal course issuer bid (&quot;NCIB&quot;), and compliance with applicable
laws and regulations pertaining to NCIBs; compliance with applicable credit facility covenants and the components of our leverage ratios
(as defined in our credit facility); our maintenance of sufficient financial resources to fund currently anticipated financial actions
and obligations and to pursue desirable business opportunities; global tax legislation changes; the timing, execution and effect of restructuring
actions; and no unforeseen adverse changes in the regulatory environment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward-looking statements
are not guarantees of future performance and the Company's actual results may differ significantly from the results discussed in the forward-looking
statements. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should known
or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially
from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements,
and you are cautioned not to put undue reliance on forward-looking statements. Forward-looking statements speak only as of the date on
which they are made, and we undertake no obligation to publicly update forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law or by the rules and regulations of the Commission. You are advised, however, to
consult any further disclosures we make on related subjects. A detailed discussion of these and other risks and uncertainties that could
cause actual results and events to differ materially from such forward-looking statements is included in Part I, Item 1A of our most recent
Annual Report on Form 10-K and in any subsequent Quarterly Reports on Form 10-Q in the section titled &quot;Risk Factors&quot; and as
may be included from time to time in our reports filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before making an investment
decision, you should carefully consider the risks described in the section captioned &quot;Risk Factors&quot; in any applicable prospectus
supplement, as well as those set forth in documents we incorporate by reference in this prospectus and any applicable prospectus supplement,
including the &quot;Risk Factors&quot; section of our most recent Annual Report on Form 10-K, and any updates to those Risk Factors in
subsequently filed Quarterly Reports on Form 10-Q or Current Reports on Form 8-K that we incorporate by reference in this prospectus and
any applicable prospectus supplement, together with all of the other information appearing in this prospectus and any applicable prospectus
supplement. Each of the risks described in these sections and documents could materially and adversely affect our business, financial
condition, results of operations and prospects. Additional unknown risks and uncertainties, or those that we deem immaterial, may also
impair our business, financial condition, results of operations and prospects. The trading price of our securities could decline due to
any of these risks, and you may lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see &quot;Where You
Can Find More Information&quot; and &quot;Incorporation of Certain Information by Reference&quot; for information on where you can find
the documents we have filed with or furnished to the Commission and which documents are incorporated into this prospectus by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will retain broad discretion
over the use of the net proceeds from the sale of our securities under this prospectus. Unless we specify otherwise in any prospectus
supplement, we intend to use the net proceeds from the sale of the securities covered by this prospectus for general corporate purposes,
including, without limitation, working capital, the repayment of existing debt, and/or financing capital investments or acquisitions.
We may temporarily invest funds that we do not need immediately for these purposes in short-term marketable securities. We will not receive
any proceeds from the sale of common shares by any selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_007"></A>DESCRIPTION OF SHARE CAPITAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The rights of our shareholders
are governed by the OBCA, our Restated Articles of Incorporation (&quot;Articles&quot;), and our by-laws (&quot;By-laws&quot;). Our authorized
share capital consists of an unlimited number of common shares, without nominal or par value, and an unlimited number of preferred shares,
issuable in series, without nominal or par value. The following description is a summary of the material terms of our common shares. You
should refer to each of our Articles and By-laws for complete information regarding its respective provisions, copies of which are incorporated
by reference as exhibits to the Registration Statement of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Common Shares</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><U>Dividends</U>. Subject to the prior rights of
the holders of preferred shares, the holders of common shares shall be entitled to receive dividends, and the Company shall pay dividends
on the common shares, as and when declared by the board of directors of the Company (the &quot;Board&quot;), in such amount and in such
form as the Board may from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Voting
Rights</U></FONT>. The holders of the common shares shall be entitled to receive notice of and to attend all meetings of shareholders
of the Company, and to vote together at all such meetings, except meetings at which only the holders of one class or series of shares
are entitled to vote separately as a class or series, as the case may be. The holders of common shares shall be entitled to one vote per
share at any meeting of holders of common shares at which they are entitled to vote separately as a class. Generally, all matters to be
voted on by shareholders must be approved by a simple majority (or, in the case of election of directors where the number of candidates
nominated for election exceeds the number of directors to be elected, by a plurality, and in the case of an amalgamation or amendments
to our Articles, by two-thirds) of the votes cast in respect of common shares held by persons present in person or by proxy, voting together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Rights
on Dissolution</U></FONT>. In the event of the liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary,
or any other distribution of the assets of the Company among its shareholders for the purpose of winding-up its affairs, subject to the
prior rights of the holders of preferred shares, the holders of the common shares then outstanding shall be entitled to receive the remaining
property and assets of the Company rateably according to the number of common shares held by each holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Other Rights</U>. The common
shares are not redeemable, nor do the holders of such shares have pre-emptive purchase rights. Directors do not stand for re-election
at staggered intervals. Other than under applicable securities laws, there are no restrictions on the transferability of common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Substantial
Shareholders</U></FONT>. There are no provisions in the Articles or the Company's By-laws discriminating against any existing or prospective
holder of our securities as a result of such shareholder owning a substantial number of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, transactions involving
shareholders that hold a substantial number of securities may be subject to Multilateral Instrument 61-101 Protection of Minority Security
Holders in Special Transactions (&quot;MI 61-101&quot;). MI 61-101 contains requirements in connection with certain types of transactions
including related party transactions. Related party transactions include, for an issuer, certain types of transactions between the issuer
and a person that is a related party of the issuer at the time the transaction is agreed to, whether or not there are also other parties
to the transaction. Related parties of an issuer include, among others, control persons of the issuer, directors, senior officers and
persons that have beneficial ownership or control or direction over (or a combination thereof), directly or indirectly, 10% of the voting
securities of the issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the availability
of certain exemptions, MI 61-101 provides certain procedural protections for minority or disinterested shareholders in connection with
the types of transactions that are subject to MI 61-101. In particular, MI 61-101 requires, subject to certain exemptions: (i) more detailed
disclosure in the proxy material sent to security holders in connection with a transaction; (ii) the preparation of a formal valuation
of the subject matter of the transaction; and (iii) minority approval of the proposed transaction by a majority of the votes cast by minority
or disinterested shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Modification,
Sub-division and Consolidation</U></FONT>. Any modification to the provisions attaching to the common shares requires the affirmative
vote of two-thirds of the votes cast by the holders of common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Creation
of Other Voting Shares</U></FONT>. The Company may not create any class or series of shares, or issue any shares of any class or series
(other than common shares) having the right to vote generally on all matters that may be submitted to a vote of shareholders (except matters
for which applicable law requires the approval of holders of another class or series of shares voting separately as a class or series)
without the separate affirmative vote of two-thirds of the votes cast by the holders of common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Change
of Control</U></FONT>. There are no provisions in the Articles or our By-laws that have been adopted in order to have the effect of delaying,
deferring or preventing a change in control of the Company and that operate only with respect to an extraordinary corporate transaction
involving the Company (or any of its subsidiaries), such as a merger, reorganization, tender offer, sale or transfer or substantially
all of its assets, or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Changes
in the Capital of the Company</U></FONT>. There are no provisions in the Articles or our By-laws which are more stringent than those required
by the OBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Advance
Notice By-law</U></FONT>. The Company's advance notice by-law (the &quot;Advance Notice By-Law&quot;), among other things, provides that
shareholders seeking to nominate, in compliance with the Advance Notice By-Law, candidates for election as directors must give timely
notice in writing to the Corporate Secretary of the Company. The Advance Notice By-Law does not interfere with the ability of shareholders
to requisition a meeting or to nominate directors by way of a shareholder proposal in accordance with the OBCA. To be timely, such notice
must be properly given (i) in the case of an annual meeting (including an annual and special meeting) of shareholders, not less than 30
days prior to the date of the meeting; provided, however, that in the event that the meeting is to be held on a date that is less than
50 days after the date (the &quot;Notice Date&quot;) on which the first disclosure in a press release reported by a national news service
in Canada, or in a document publicly filed by the Corporation under its profile both on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov,of
the date of the meeting was made, notice by the nominating shareholder must be properly given not later than the close of business on
the tenth day following the Notice Date; (ii) in the case of a special meeting (which is not also an annual meeting) of shareholders called
for the purpose of electing directors (whether or not also called for other purposes), not later than the close of business on the fifteenth
day following the Notice Date; and (iii) notwithstanding the foregoing, in the case of an annual meeting of shareholders or a special
meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not also called
for other purposes) where &quot;notice-and-access&quot; is used for delivery of proxy-related materials and the Notice Date is not less
than 50 days before the date of the meeting, not less than 40 days prior to the date of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Advance Notice By-Law
also prescribes the proper written form for a shareholder's notice as well as additional requirements in connection with nominations.
Except as otherwise provided by applicable law and the Articles, no person will be eligible for election as a director of the Company
unless nominated in accordance with the provisions of the Company's Advance Notice By-Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Advance Notice By-Law
authorizes the chair of the meeting to determine whether a nomination was made in accordance with the procedures set forth in the Advance
Notice By-Law and, if any proposed nomination is not in compliance with the Advance Notice By-Law, to declare that such defective nomination
shall be disregarded. The Board may, in its sole discretion, waive any requirements of the Advance Notice By-Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Rights
to Own Securities</U></FONT>. There are no limitations under our Articles, By-laws or in the OBCA on the rights to own our securities,
including the rights of non-resident or foreign shareholders to hold or exercise voting rights on our securities, except that certain
transactions under the Investment Canada Act may require that a &quot;non-Canadian&quot; not acquire &quot;control&quot; of the Company
without prior review and approval by the Minister of Innovation, Science and Industry. The acquisition of one-third or more of the voting
shares of the Company would give rise to a rebuttable presumption of the acquisition of control, and the acquisition of more than fifty
percent of the voting shares of the Company would constitute an acquisition of control. In addition, the Investment Canada Act provides
the Canadian government with broad discretionary powers in relation to national security to review and potentially prohibit, condition
or require the divestiture of, any investment in the Company by a non-Canadian, including non-control level investments. &quot;Non-Canadian&quot;
generally means an individual who is neither a Canadian citizen nor a permanent resident of Canada within the meaning of the Immigration
and Refugee Protection Act (Canada) who has been ordinarily resident in Canada for not more than one year after the time at which he or
she first became eligible to apply for Canadian citizenship, or a corporation, partnership, trust or joint venture that is ultimately
controlled by non-Canadians.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, limitations on
the ability to acquire and hold shares of the Company may be imposed by the Competition Act (Canada) (the &quot;Competition Act&quot;).
This legislation grants the Commissioner of Competition (the &quot;Commissioner&quot;) jurisdiction, for up to three years, to challenge
the acquisition of an interest in us before the Competition Tribunal if the Commissioner believes that it would, or would be likely to,
result in a substantial lessening or prevention of competition in any market in Canada. The Competition Act requires that any person proposing
to acquire any of the assets in Canada of an operating business file a notification with the Competition Bureau where specified &quot;size
of the parties&quot; and &quot;size of the transaction&quot; thresholds are exceeded. In the case of share acquisitions, an additional
 &quot;shareholding threshold&quot; applies. Any person who intends to acquire shares must file a notification with the Competition Bureau
if certain financial thresholds are exceeded, and that person would hold more than 20% of our voting shares as a result of the acquisition.
If a person already owns more than 20% of our voting shares, a notification must be filed when the acquisition would bring that person's
holdings over 50%. Where a notification is required, the legislation prohibits completion of the acquisition until the expiration of a
statutory waiting period or unless the Commissioner waives the waiting period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Preferred Shares</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company's Board may issue
preferred shares from time to time in one or more series, and (subject to the provisions of the Articles) determine the designation of,
and the rights, privileges, restrictions and conditions attaching to, such shares (including, without limitation, dividend rights, cancellation,
retraction or redemption rights, voting rights, conversion or exchange rights, sinking fund provisions and/or other provisions). Preferred
shares of each series will rank as to dividends (to the extent cumulative dividends are applicable) and capital on a parity with preferred
shares of every other series. Preferred shares of each series will rank as to dividends and capital senior to the common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to a distribution of assets in the
event of a liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, or any other distribution of the assets
of the Company for the purpose of winding up its affairs, holders of preferred shares of each series will be entitled to receive from
the assets of the Company in respect of each such share held a sum equal to the amount in the stated capital account for such series divided
by the number of shares in such series then outstanding, together with any accrued (in the case of cumulative dividends) or declared (in
the case of non-cumulative dividends) and unpaid dividends thereon, before any amount shall be paid or any assets are distributed to the
holders of common shares. Upon the receipt of such sum, the holders of preferred shares shall not be entitled to share in the distribution
of our remaining assets and their preferred shares will be canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are currently no preferred shares outstanding.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The material terms of any
preferred shares that we offer through a prospectus supplement will be described in that prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_008"></A>DESCRIPTION OF OTHER SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Description of Debt Securities</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a general
description of the debt securities which may be issued from time to time by us under this prospectus. The particular terms of any debt
securities offered will be described in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The Indenture</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The debt securities covered
by this prospectus may be issued in one or more series under an indenture dated as of a date on or prior to the issuance of the debt securities
to which it relates between us and the trustee named therein, and pursuant to an applicable prospectus supplement. The form of the indenture
has been filed as an exhibit to the registration statement of which this prospectus is a part. If we issue debt securities, we will file
any final indenture and any supplemental indenture or officer's certificate related to the particular series of debt securities issued
with the Commission, and you should read those documents for further information about the terms and provisions of such debt securities.
See &quot;Where You Can Find More Information.&quot; We refer to such indenture, as amended or supplemented from time to time, as the
 &quot;Indenture.&quot; The Indenture will be subject to, and governed by, the United States Trust Indenture Act of 1939, as amended (the
 &quot;Trust Indenture Act&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
sets forth certain general terms and provisions of the debt securities and the Indenture. The statements below are not complete and are
subject to, and are qualified in their entirety by reference to, all of the provisions of the Indenture. This summary is also subject
to, and qualified by, the description of the particular terms and provisions of the debt securities included in the applicable prospectus
supplement. The applicable prospectus supplement may add to, update or change the general terms described below. Accordingly, you should
read the summary below, the applicable prospectus supplement, the provisions of the Indenture (including any applicable supplement thereto),
and any related documents before investing in our debt securities. If there is any inconsistency between the terms presented here and
those in the applicable prospectus supplement, the terms of the prospectus supplement will supersede the terms presented here.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain of our subsidiaries
may guarantee the debt securities we offer. Those guarantees may or may not be secured by liens, mortgages, and security interests in
the assets of those subsidiaries. The terms and conditions of any such subsidiary guarantees, and a description of any such liens, mortgages
or security interests, will be set forth in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no requirement under
the Indenture that future issues of our debt securities be issued under such Indenture, and we will be free to use other indentures or
documentation containing provisions different from those included in the Indenture or applicable to one or more series of debt securities,
in connection with future issues of such other debt securities.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">References to &quot;us&quot;
or &quot;we&quot; in this description of debt securities means Celestica Inc., but not any of our subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits us to
issue from time to time senior or subordinated, secured or unsecured, debentures, notes or other evidences of indebtedness, issuable in
one or more series (with the same or various maturities, at par, at a premium or at a discount), which may be convertible into or exchangeable
for any securities of any person (including us). The Indenture permits us to establish the terms of each series of debt securities at
the time of issuance, and does not limit the aggregate amount of debt securities that we may issue thereunder. The prospectus supplement
relating to any series of debt securities that we may offer will contain the specific terms of the debt securities. Those specific terms
will include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the title of the debt securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the price or prices at which we will issue the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the price or prices at which we will issue the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any limit upon the aggregate principal amount of the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the date or dates on which we will pay the principal of the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the rate or rates (which may be fixed or variable) per annum or the method used to determine such rate
or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the debt securities
will bear interest, the date or dates from which such interest, if any, will accrue, the date or dates on which such interest, if any,
will commence and be payable and any regular record date for the interest payable on any interest payment date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the place or places where the principal of, premium, if any, and interest, if any, on the debt securities
will be payable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms and conditions upon which we may redeem the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous
provisions or at the option of a holder thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any dates on which and the price or prices at which we will repurchase the debt securities at the option
of the holders thereof and other detailed terms and provisions of any such repurchase obligations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the denominations in which the debt securities will be issuable, if other than minimum denominations of
$2,000 and integral multiples of $1,000 in excess thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether the debt securities will be issued in bearer or fully registered form (and, if in fully registered
form, whether the debt securities will be issuable as global debt securities);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if other than the principal amount thereof, the portion of the principal amount of the debt securities
that will be payable upon declaration of acceleration of the maturity date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether the debt securities will be &quot;original issue discount&quot; securities for United States federal
income tax purposes;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the designation of the currency or currencies in which payment of the principal of, premium and interest,
if any, on the debt securities will be made if other than United States dollars;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether, under what circumstances, and the currency in which the Company will pay certain additional amounts
to holders who are not Canadian persons in respect of specified tax, assessment or governmental charges and, if so, whether we will have
the option to redeem such debt securities rather than pay such additional amounts (and the terms of any such option);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the provisions, if any, relating to any security provided for the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether the debt securities will be senior debt securities or subordinated debt securities, and if they
are subordinated, the terms of the subordination;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether payments on the debt securities may be made, at our or the holder's election, in a currency other
than that in which such debt securities are stated to be payable, and the manner of determining the applicable exchange rate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms of any guarantee of payment obligations with respect to the debt securities and any corresponding
changes to the provisions of this Indenture as then in effect;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if the debt securities are to be convertible into or exchangeable for any securities (including those
of the Company), the terms and conditions of any such conversion or exchange;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">provisions for electronic issuances of debt securities or debt securities in uncertificated form;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any addition to or change in the events of default or the acceleration provisions described in the Indenture
with respect to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any addition to or change in the covenants described in the Indenture with respect to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any selling restrictions applicable to the debt securities, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other terms of the debt securities which may modify or delete any provision of the Indenture as it
applies to such debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with
respect to the debt securities if other than those appointed in the Indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue additional debt
securities of a particular series without the consent of the holders of the debt securities of such series outstanding at the time of
issuance. In addition, we will describe in the applicable prospectus supplement material U.S. federal tax considerations and any other
special considerations for any debt securities we sell which are denominated in a currency or currency unit other than U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as specifically described
in the applicable prospectus supplement, the Indenture does not contain any covenants designed to protect holders of the debt securities
against a reduction in our creditworthiness in the event of a highly leveraged transaction or to prohibit other transactions which may
adversely affect holders of the debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><B>Exchange and Transfer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Debt securities may be transferred
or exchanged at the office of the registrar or co-registrar designated by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will not impose a service
charge for any transfer or exchange, but we may require holders to pay any tax or other governmental charges associated with any transfer
or exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">In the event of
any redemption of debt securities of any series, we will not be required to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">issue, register the transfer of, or exchange, any debt security of that series during a specified period
before sending a notice of redemption; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">register the transfer of or, exchange any, debt security of that series selected, called or being called
for redemption, in whole or in part, except the unredeemed portion of any series being redeemed in part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may initially appoint the
trustee as the registrar. Any transfer agent, in addition to the registrar initially designated by us, will be named in the prospectus
supplement. We may designate additional transfer agents or change transfer agents or change the office of the transfer agent. However,
we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Global Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The debt securities of any
series may be represented, in whole or in part, by one or more global securities. Each global security will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">be registered in the name of a depositary that we will identify in a prospectus supplement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">be deposited with the trustee as custodian for the depositary or its nominee; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">bear any required legends.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No global security may be
exchanged in whole or in part for debt securities registered in the name of any person other than the depositary or any nominee unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the depositary has notified us that it is unwilling or unable to continue as depositary or has ceased
to be qualified to act as depositary, and in either case we fail to appoint a successor depositary registered as a clearing agency under
the Exchange Act within 90 days of such event;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">we execute and deliver to the trustee an officer's certificate to the effect that such global securities
shall be so exchangeable; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">an event of default with respect to the debt securities represented by such global securities shall have
occurred and be continuing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As long as the depositary,
or its nominee, is the registered owner of a global security, the depositary or nominee will be considered the sole owner and holder of
the debt securities represented by the global security for all purposes under the Indenture. Except in the above limited circumstances,
owners of beneficial interests in a global security:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">will not be entitled to have the debt securities registered in their names;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">will not be entitled to physical delivery of certificated debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">will not be considered to be holders of those debt securities under the Indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payments on a global security
will be made to the depositary or its nominee as the holder of the global security. Some jurisdictions have laws that require that certain
purchasers of securities take physical delivery of such securities in definitive form. These laws may impair the ability to transfer beneficial
interests in a global security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Institutions that have accounts
with the depositary or its nominee are referred to as &quot;participants.&quot; Ownership of beneficial interests in a global security
will be limited to participants and to persons that may hold beneficial interests through participants. The depositary will credit, on
its book-entry registration and transfer system, the respective principal amounts of debt securities represented by the global security
to the accounts of its participants. Each person owning a beneficial interest in a global security must rely on the procedures of the
depositary (and, if such person is not a participant, on procedures of the participant through which such person owns its interest) to
exercise any rights of a holder under the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ownership of beneficial interests
in a global security will be shown on and effected through records maintained by the depositary, with respect to participants' interests,
or by any participant, with respect to interests of persons held by participants on their behalf. Payments, transfers and exchanges relating
to beneficial interests in a global security will be subject to policies and procedures of the depositary. The depositary's policies and
procedures may change from time to time. Neither we nor the trustee will have any responsibility or liability for the depositary's acts
or omissions or any participant's records with respect to beneficial interests in a global security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><B>Payment and Paying Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions of this subsection
will apply to the debt securities unless otherwise indicated in the prospectus supplement. Payment of interest on a debt security on any
interest payment date will be made to the person in whose name the debt security is registered at the close of business on the regular
record date. Payment on debt securities of a particular series will be payable at the office of a paying agent or paying agents designated
by us. However, at our option, we may pay interest by mailing a check to the record holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also name any other
paying agents in the prospectus supplement. We may designate additional paying agents, change paying agents or change the office of any
paying agent. However, we will be required to maintain a paying agent in each place of payment for the debt securities of a particular
series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to any applicable
abandoned property law, all moneys paid by us to a paying agent for payment on any debt security that remain unclaimed at the end of two
years after such payment was due will be repaid to us. Thereafter, the holder may look only to us for such payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Covenants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any series of debt securities
may have covenants in addition to or differing from those included in the Indenture, limiting or restricting, among other things: our
ability to incur either secured or unsecured debt, or both; our ability to make certain payments, dividends, redemptions or repurchases;
our ability to create dividend and other payment restrictions affecting our subsidiaries; our ability to make investments; mergers and
consolidations by us or our subsidiaries; sales of assets by us; our ability to enter into transactions with affiliates; our ability to
incur liens; and/or sale and leaseback transactions. Any such additional or different covenants will be described in the applicable prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Events of Default</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of the following constitutes
an event of default for a series of debt securities unless it is either inapplicable to a particular series or it is specifically deleted
or modified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">default for 30 days in the payment of any interest when due;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">default in the payment of principal, or premium, if any, when due at maturity, upon acceleration, declaration
or redemption or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">default in the performance, or breach, of any covenant or warranty in the Indenture (or applicable board
resolution or officer's certificate) for 90 days after specified written notice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">certain events of bankruptcy, insolvency or reorganization; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other event of default provided with respect to debt securities of that series.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to furnish
the trustee annually with an officer's certificate as to our compliance with all conditions and covenants under the Indenture. The Indenture
provides that the trustee may withhold notice to holders of debt securities of any default, except in respect of the payment of the principal
of, premium, if any, or interest on the debt securities, if it considers it in the interests of the holders of the debt securities to
do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>Effect of an Event of Default</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If
an event of default exists with respect to debt securities of any series (other than an event of default in the case of certain events
of bankruptcy set forth in the Indenture), the trustee or the holders of a specified percentage in aggregate principal amount of such
series outstanding may declare the principal amount of, and all accrued but unpaid interest, if any, on all outstanding debt securities
of that series to be due and payable immediately, by a notice in writing to us, and to the trustee if given by holders. Upon that declaration,
such amounts will become immediately due and payable. However, at any time after a declaration of acceleration has been made, but before
a judgment or decree for payment of the money due has been obtained, the holders of a majority in principal amount of the outstanding
securities of that series, by written notice to us and the trustee, may rescind and annul such declaration and consequences, subject to
conditions specified in the Indenture. If an event of default in the case of certain events of bankruptcy, insolvency or reorganization
exists, the principal amount of, and accrued and unpaid interest, if any, on all debt securities outstanding under the Indenture shall
automatically, and without any declaration or other action on the part of the trustee or any holder of such outstanding debt, become immediately
due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>Legal Proceedings and Enforcement of Right to Payment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of any series of debt
securities may not pursue any remedy with respect to the Indenture or such debt securities unless: (i) they have given to the trustee
written notice of a continuing event of default with respect to debt securities of that series; (ii) holders of a specified percentage
of the aggregate principal amount of the then-outstanding debt securities of that series make a written request to the trustee to pursue
the remedy; (iii) such holders must have offered and, if requested, provide to the trustee security or indemnity satisfactory to the trustee
against any loss, liability or expense, (iv) the trustee does not comply with the request within a specified number of days after receipt
of the request and the offer, and if requested, the provision or security or indemnity; and (v) during such period the holders of a majority
in aggregate principal amount of the then-outstanding debt securities of such series do not give the trustee a direction inconsistent
with that request. However, holders of debt securities will have an absolute and unconditional right to receive payment of the principal
of, premium, if any, and interest, if any, thereon on the due dates expressed therein and to institute a suit for the enforcement of that
payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Satisfaction and Discharge of Indenture</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture will cease to
be of further effect with respect to any series of debt securities (except as to certain limited surviving rights), when</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify">either:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="text-align: justify">all securities of such series that have been authenticated and delivered (except lost, stolen or destroyed
securities that have been replaced or paid and securities for whose payment money has been deposited in trust and thereafter repaid to
the Company), have been delivered to the trustee for cancellation; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="text-align: justify">all securities of such series that have not been delivered to the trustee for cancellation have become
due and payable or will become due and payable within one year, and we have irrevocably deposited or caused to be deposited with the trustee
the requisite amounts to pay and discharge the entire indebtedness on such securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify">no default or event of default has occurred and is continuing
on the date of such deposit (other than a default or event of default resulting from the borrowing of funds to be applied to such deposit)
and the deposit will not result in a breach or violation of, or constitute a default under, any other material instrument to which we
are, or any guarantor is, as applicable, a party or by which we are, or any guarantor is, as applicable, bound;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD STYLE="text-align: justify">we have or any guarantor of such Notes has paid or caused to
be paid all applicable sums payable under this Indenture;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT></TD><TD STYLE="text-align: justify">we have delivered irrevocable instructions to the trustee to
apply the deposited money toward the payment of the securities of such series at maturity or on the redemption date, as the case may
be; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT></TD><TD STYLE="text-align: justify">we have delivered to the trustee an officer's certificate and an opinion of counsel, each stating that
all conditions precedent relating to the satisfaction and discharge of the Indenture as to such series have been complied with.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Amendment, Supplement and Waiver</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We and the trustee may amend
and/or supplement the Indenture with the consent of the holders of a majority in aggregate principal amount of the outstanding debt securities
of each series affected. However, without the consent of each holder affected, an amendment or waiver (described below) may not, with
respect to any debt securities held by a non-consenting holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce the principal amount, any premium or change the stated maturity of any debt security or alter or
waive any of the provisions with respect to the redemption or repurchase of such debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce the rate (or alter the method of computation) of or extend the time for payment of interest, including
defaulted interest, on any debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">waive a default or event of default in the payment of principal of or premium, if any, or interest on
such debt securities, except a rescission of acceleration of such securities by the holders of at least a majority in aggregate principal
amount of the then outstanding securities of the applicable series with respect to a nonpayment default and a waiver of the payment default
that resulted from such acceleration;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">make the principal of or premium, if any or interest on any debt security payable in currency other than
that stated therein;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">change any place of payment where the debt securities or interest thereon is payable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">adversely affect any right to convert or exchange any debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">make any change in the provisions of the Indenture relating to waivers of past defaults or the rights
of holders of the debt securities to receive payments of principal of, premium, or interest, if any, thereon and/or to institute suit
for the enforcement of any such payments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">change any obligation of the Company to pay specified additional amounts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">make any change in the foregoing amendment and waiver provisions; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce the percentage in principal amount of any debt securities, the consent of the holders of which
is required for any of the foregoing modifications or otherwise necessary to modify or amend the Indenture or to waive any past defaults.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the restrictions
set forth above, the holders of a majority in aggregate principal amount of the outstanding debt securities of a series may, on behalf
of the holders of all debt securities of that series, waive compliance by us with any provision of the Indenture or the debt securities
with respect to such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of a majority
in aggregate principal amount of the outstanding debt securities of a series may, on behalf of the holders of all debt securities of that
series, generally waive any past default under the Indenture and the consequences of such default. However, a default in respect of a
covenant or provision of the Indenture that cannot be modified or amended without the consent of the holder of each outstanding debt security
affected, or a default in the payment of the principal of, or premium, if any, or any interest on, any debt security, cannot be so waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Merger, Consolidation or Transfer of Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will not consolidate or
amalgamate with or merge into or enter into any statutory arrangement with any other person or entity or sell, convey, transfer, lease
or otherwise dispose of all or substantially all of our and our subsidiaries' properties and assets, taken as a whole (a &quot;Transfer&quot;),
to any person or entity, unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify">the entity formed by such consolidation or amalgamation or into
which we are merged, or to which such Transfer is made: (i) is a corporation, limited liability company, partnership, trust or other
entity organized and existing under the laws of Canada or any province or territory thereof, the United States, any state thereof or
the District of Columbia; and (ii) expressly assumes all of our obligations under the outstanding debt securities and the Indenture,
pursuant to a supplemental Indenture in form reasonably satisfactory to the trustee;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify">&#8239;immediately after giving effect to such transaction,
no default or event of default under the Indenture shall have occurred and be continuing; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD STYLE="text-align: justify">we (or the surviving entity) shall have delivered to the trustee an officer's certificate and an opinion
of counsel, each stating that all conditions precedent relating to such transaction have been complied with.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The requirements of paragraphs
(a) and (b) above do not apply to (1) any merger, amalgamation or consolidation in which we are the surviving corporation or (2) any Transfer
by us to a direct or indirect wholly owned subsidiary that is a guarantor or obligor of the debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Certain Covenants with respect to Canadian Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If specified pursuant to the
Indenture, all payments made by us under or with respect to the securities of any series will be made free and clear of and without withholding
or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge (including penalties,
interest and other liabilities related thereto) imposed or levied by or on behalf of the Government of Canada or of any province or territory
thereof or by any authority or agency therein or thereof having power to tax (&quot;Canadian Taxes&quot;), unless we are required to withhold
or deduct Canadian Taxes by law or by the interpretation or administration thereof by the relevant governmental authority or agency. If
we are so required to withhold or deduct any amount for or on account of Canadian Taxes from any payment made under or with respect to
the securities, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional
amounts) after such withholding or deduction will not be less than the amount the holder would have received if such Canadian Taxes had
not been withheld or deducted (a similar payment will also be made to holders that are exempt from withholding but are required to pay
tax directly on amounts otherwise subject to withholding); provided that no additional amounts will be payable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="text-align: justify">where such taxes are required to be withheld or deducted as
a result of such person or entity not dealing at arm's length with us (within the meaning of the Income Tax Act (Canada)) at the time
of the making of such payment;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="text-align: justify">where such taxes are required to be withheld or deducted as
a result of such person or entity being, or not dealing at arm's length with, a &quot;specified shareholder&quot; of the Company (within
the meaning of the Income Tax Act (Canada));</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: justify">to any person or entity by reason of their being connected with
Canada (otherwise than merely by holding or ownership of any series of securities or receiving any payments or exercising any rights
thereunder), including without limitation a nonresident insurer who carries on an insurance business in Canada and in a country other
than Canada;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)</FONT></TD><TD STYLE="text-align: justify">for or on account of any tax, assessment or other governmental
charge which would not have been so imposed but for the presentation by the holder of such security or coupon for payment on a date more
than 10 days after the date on which such payment became due and payable or the date on which payment thereof is duly provided for, whichever
occurs later;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD><TD STYLE="text-align: justify">for or on account of any estate, inheritance, gift, sales, transfer,
personal property tax or any similar tax, assessment or other governmental charge;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6)</FONT></TD><TD STYLE="text-align: justify">for or on account of any tax, assessment or other governmental
charge required to be withheld by any paying agent from any payment to a person or entity in respect of any security, if such payment
can be made without such withholding by at least one other paying agent the identity of which is provided to such person or entity;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7)</FONT></TD><TD STYLE="text-align: justify">for or on account of any tax, assessment or other governmental
charge which is payable otherwise than by withholding from a payment in respect of such security;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8)</FONT></TD><TD STYLE="text-align: justify">to any person or entity which is subject to such Canadian Taxes
by reason of its failure to comply with any certification, identification, information, documentation or other reporting requirement
if compliance is required by law, regulation, administrative practice or an applicable treaty as a precondition to (or to reasonably
evidence) exemption from, or a reduction in the rate of deduction or withholding of, such Canadian Taxes; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9)</FONT></TD><TD STYLE="text-align: justify">for any combination of items (1) - (8) above;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">nor will additional amounts be paid with respect
to any payment on a security to a holder who is a fiduciary or partnership or other than the sole beneficial owner of such payment to
the extent such payment would be required by the laws of Canada (or any political subdivision thereof) to be included in the income for
Canadian federal income tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial
owner who would not have been entitled to payment of the additional amounts had such beneficiary, settlor, member or beneficial owner
been the holder of such security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Defeasance and Covenant Defeasance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may discharge all of our
obligations with respect to any series of debt securities at any time, and we may also be released from our obligations under certain
covenants and from certain other obligations, and elect not to comply with those covenants and obligations without creating an event of
default. Discharge under the first procedure is called &quot;defeasance&quot; and under the second procedure is called &quot;covenant
defeasance.&quot;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Defeasance or covenant defeasance
may be effected only if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="text-align: justify">We irrevocably deposit with the trustee: an amount (in the currency
in which such securities are then specified as payable at maturity); specified government obligations; or a combination thereof, sufficient,
in the written opinion of a nationally recognized investment bank, appraisal firm, or firm of independent public accountants delivered
to the trustee, to pay the principal of (and premium, if any) and interest, if any, on the applicable securities at maturity (or redemption
date, if applicable);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="text-align: justify">No default or event of default shall have occurred and be continuing
on the date of such deposit;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: justify">Such defeasance or covenant defeasance shall not result in a
breach or violation of, or constitute a default under any material agreement or instrument (other than the Indenture) to which we are
a party or are bound;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)</FONT></TD><TD STYLE="text-align: justify">In the case of a defeasance election by us, we shall have delivered
to the trustee an opinion of counsel stating that (x) we have received from, or there has been published by, the U.S. Internal Revenue
Service a ruling, or (y) since the date of execution of the Indenture, there has been a change in the applicable U.S. federal income
tax law, in either case to the effect that, and based thereon such opinion of counsel will confirm that, the beneficial owners of such
securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such defeasance and will be subject
to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such defeasance
had not occurred;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD><TD STYLE="text-align: justify">In the case of a covenant defeasance election by us, we shall
have delivered to the trustee an opinion of counsel confirming that the beneficial owners of such securities will not recognize income,
gain or loss for U.S. federal income tax purposes as a result of such covenant defeasance and will be subject to U.S. federal income
tax on the same amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6)</FONT></TD><TD STYLE="text-align: justify">We have delivered to the trustee either an opinion of Canadian
counsel or a ruling from the Canada Revenue Agency, in either case to the effect that the holders of such securities will not recognize
income, gain or loss for Canadian federal, provincial or territorial income tax or other tax purposes as a result of such defeasance
or covenant defeasance and will be subject to Canadian federal or provincial income tax and other tax on the same amounts, in the same
manner and at the same times as would have been the case had such defeasance or covenant defeasance not occurred (and for the purposes
of such opinion of counsel, such Canadian counsel shall assume that holders include holders who are not resident in Canada);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7)</FONT></TD><TD STYLE="text-align: justify">We have delivered to the trustee an officer's certificate stating
that the deposit was not made by us with the intent of preferring the holders of such debt securities over our other creditors with the
intent of defeating, delaying or defrauding any creditors of the Company or others;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8)</FONT></TD><TD STYLE="text-align: justify">We are not an &quot;insolvent person&quot; within the meaning
of the Bankruptcy and Insolvency Act (Canada) on the date of such deposit or at any time during a specified period after the date of
such deposit (it being understood that this condition shall not be deemed satisfied until the expiration of such period); and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9)</FONT></TD><TD STYLE="text-align: justify">We shall have delivered to the trustee an officer's certificate and an opinion of counsel, each stating
that all conditions precedent relating to either the defeasance or the covenant defeasance have been complied with.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture and the debt
securities shall be governed by and construed in accordance with the laws of the State of New York without regard to its principles of
conflict of laws. The Indenture is subject to the provisions of the Trust Indenture Act that are required to be a part of the Indenture
and shall, to the extent applicable, be governed by such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Concerning the Trustee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trustee will have all
the duties and responsibilities of an indenture trustee specified in the Trust Indenture Act with respect to any debt securities issued
under the Indenture. The trustee will not be required to expend or risk its own funds or otherwise incur financial liability in performing
its duties or exercising its rights and powers if it reasonably believes that it is not reasonably assured of repayment or adequate indemnity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Description of Warrants</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue warrants in one
or more series to purchase common shares, preferred shares, debt securities or other securities under this prospectus. Warrants may be
issued independently or together with any other securities and may be attached to, or separate from, such securities. Each series of warrants
will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The terms of any warrants to be issued
and a description of the material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement.
We expect that such terms will include, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the title of such warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the aggregate number of such warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the price or prices at which such warrants will be issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the number and type of securities purchasable upon exercise of such warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the price at which our securities purchasable upon exercise of such warrants may be purchased;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the date on which the right to exercise such warrants shall commence and the date on which such right
shall expire;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, the designation and terms of the securities with which such warrants are issued and the
number of such warrants issued with each such security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, the date on and after which such warrants and the related securities will be separately
transferable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">information with respect to book-entry procedures, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, a discussion of any material U.S. federal or Canadian income tax considerations; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other terms of such warrants, including terms, procedures and limitations relating to the exchange
and exercise of such warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_009"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We or any selling shareholder
may sell the securities described in this prospectus in any one or more of the following ways from time to time: (i) through agents; (ii)
to or through underwriters, including through underwriting syndicates represented by managing underwriters; (iii) through brokers or dealers;
(iv) directly by us to purchasers pursuant to applicable statutory exemptions; or (v) through a combination of any of these methods of
sale. We will set forth in an applicable prospectus supplement a description of the specific types of securities that may be offered under
this prospectus. The terms of the offering of securities, the initial offering price and the net proceeds to us will be contained in the
prospectus supplement and other offering material relating to such offer. The prospectus supplement may also add, update or change information
contained in this prospectus, and/or describe certain risks in addition to those referred to herein associated with an investment in the
specific securities offered. You should carefully read this prospectus and any applicable prospectus supplement before you invest in any
of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>By Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may designate agents who
agree to use their reasonable efforts to solicit purchases for the period of their appointment or to sell securities on a continuing basis.
Any agent involved will be named, and any commissions payable by us to such agent will be set forth, in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>By Underwriters or Dealers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If underwriters are used in
the sale, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more
transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale.
The underwriter or underwriters with respect to a particular underwritten offering of securities, or, if an underwriting syndicate is
used, the managing underwriter or underwriters, will be set forth on the cover of the applicable prospectus supplement. Unless otherwise
set forth in the prospectus supplement relating thereto, the obligations of the underwriters to purchase the securities will be subject
to certain conditions and the underwriters will be obligated to purchase all of the securities if any are purchased. We may change from
time to time any initial public offering price and any discounts or concessions the underwriters allow or re-allow or pay to dealers.
We may use underwriters with whom we have a material relationship. We will describe in the prospectus supplement naming the underwriter
the nature of any such relationship.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may grant to the underwriters
an option to purchase additional offered securities, to cover over-allotments, if any, at the public offering price (with additional underwriting
discounts or commissions), as may be set forth in the related prospectus supplement, or if applicable, the pricing supplement. If we grant
any over-allotment options, the terms of the over-allotment option will be set forth in the prospectus supplement relating to such offered
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until the distribution of
the securities is completed, rules of the Commission may limit the ability of underwriters and other participants in the offering to bid
for and purchase the securities. As an exception to these rules, the underwriters in certain circumstances are permitted to engage in
certain transactions that stabilize the price of the securities. Such transactions consist of bids or purchases for the purpose of pegging,
fixing or maintaining the price of the securities. If the underwriters create a short position in the securities in connection with the
offering by selling more securities than are set forth on the cover page of the applicable prospectus supplement or in the term sheet,
the underwriters may reduce that short position by purchasing securities in the open market. The underwriters also may impose a penalty
bid on certain underwriters. This means that if the underwriters purchase the securities in the open market to reduce the underwriters'
short position or to stabilize the price of the securities, they may reclaim the amount of the selling concession from the underwriters
who sold those securities as part of the offering. In general, purchases of a security for the purpose of stabilization or to reduce a
short position could cause the price of the security to be higher than it might be in the absence of such purchases. The imposition of
a penalty bid might also have an effect on the price of a security to the extent that it were to discourage resales of the security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If dealers are used and, if
so, specified in the applicable prospectus supplement, we will sell such securities to the dealers as principals. The dealers may then
resell such securities to the public or other dealers at fixed or varying prices to be determined by such dealers at the time of resale.
The names of the dealers and the terms of any such transaction will be set forth in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Direct Sales</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities may also be sold
directly by us. In this case, no underwriters, dealers or agents would be involved. Except as set forth in the related prospectus supplement,
none of our directors, officers or employees will solicit or receive a commission in connection with those direct sales. Those persons
may respond to inquiries by potential purchasers and perform ministerial and clerical work in connection with direct sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Delayed Delivery Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may authorize underwriters,
dealers and agents to solicit offers by certain institutions to purchase securities pursuant to delayed delivery contracts providing for
payment and delivery on a future date specified in the applicable prospectus supplement. Institutions with which delayed delivery contracts
may be made include commercial and savings banks, insurance companies, educational and charitable institutions and other institutions
we may approve. The obligations of any purchaser under any delayed delivery contract will not be subject to any conditions except that
any related sale of offered securities to underwriters shall have occurred and the purchase by an institution of the securities covered
by its delayed delivery contract shall not at the time of delivery be prohibited under the laws of any jurisdiction in the United States
to which that institution is subject. Any commission paid to underwriters, dealers and agents soliciting purchases of securities pursuant
to delayed delivery contracts accepted by us will be detailed in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Selling Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any selling shareholder may
offer common shares using any of the methods described above, through agents, underwriters, dealers or in direct sales or delayed delivery
contracts. The applicable prospectus supplement will describe the selling shareholder's method of distribution, will name any agent, underwriter
or dealer of the selling shareholder and will describe the compensation to be paid to any of these parties. In addition to distribution
as outlined above, any selling shareholders may sell their common shares pursuant to Rule 144 under the Securities Act, if applicable
and available, or any other available exemption from registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may enter into agreements
with underwriters, dealers and agents that entitle them to indemnification against certain civil liabilities, including liabilities under
the Securities Act, or to contribution with respect to payments which the underwriters, dealers or agents may be required to make. Underwriters,
dealers and agents may be customers of, may engage in transactions with, or perform services for, us or our subsidiaries in the ordinary
course of business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Underwriters, dealers and
agents that participate in the distribution of the securities may be underwriters as defined in the Securities Act, and any discounts
or commissions received by them from us and any profit on the resale of the securities by them may be treated as underwriting discounts
and commissions under the Securities Act. Any underwriters, dealers or agents used in the offer or sale of securities will be identified
and their compensation described in an applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless we state otherwise
in a prospectus supplement, we will bear the costs relating to the securities being registered under this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_010"></A>MATERIAL INCOME TAX CONSIDERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information regarding material
Canadian and U.S. federal income tax consequences to persons investing in the securities offered by this prospectus will be set forth
in an applicable prospectus supplement. You should consult your own tax advisors prior to any acquisition of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_011"></A>INCORPORATION OF CERTAIN INFORMATION BY
REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incorporate by reference
into this prospectus the following documents we have filed with the Commission:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the Company's Annual Report on Form <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1030894/000103089425000014/cls-20241231.htm" STYLE="-sec-extract: exhibit">10-K</A> for the year ended December 31, 2024 filed with the Commission on March 3, 2025;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the Company's Current Reports on Form 8-K filed with the Commission on <A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465925000168/tm2432354d1_8k.htm" STYLE="-sec-extract: exhibit">January 2, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465925005070/tm254047d1_8k.htm" STYLE="-sec-extract: exhibit">January 22, 2025</A>
and <A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465925007666/tm254558d1_8k.htm" STYLE="-sec-extract: exhibit">January 31, 2025</A>; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the description of the Company's common shares contained in its Registration Statement on Form <A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924052078/tm2411573d1_8a12ba.htm" STYLE="-sec-extract: exhibit">8-A/A</A>,
filed with the Commission on April 25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All documents subsequently
filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement
and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters
all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part
hereof from the date of filing of such documents. The Company will not, however, incorporate by reference in this Registration Statement
any documents or portions thereof that are not deemed &quot;filed&quot; with the Commission, including any information furnished by the
Company pursuant to Item 2.02 or Item 7.01 of its Current Reports on Form&#8239;8-K unless, and except to the extent, specified in such
reports.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any statement contained in
any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of
this prospectus to the extent that a statement contained herein or in any other subsequently filed or furnished document which also is
or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded
shall not be deemed to constitute a part of this prospectus, except as so modified or superseded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon written or oral request,
we will provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all of the information
that is incorporated by reference into this prospectus but not delivered with this prospectus (other than exhibits to those documents
unless such exhibits are specially incorporated by reference in those documents), at no cost, by writing to or telephoning us at the following
address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Celestica Inc.<BR>
5140 Yonge Street, Suite 1900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Toronto, Ontario</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Canada M2N 6L7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">416-448-5800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attention: Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_012"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly
and current reports, proxy statements and other information with the Commission, including the Registration Statement of which this prospectus
forms a part. The Commission maintains an internet site (<U>http://www.sec.gov</U>) that contains reports, proxy and information statements
and other information regarding issuers that file electronically with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also file reports, statements
and other information with the Canadian Securities Administrators (the &quot;CSA&quot;) and these can be accessed electronically at the
CSA's System for Electronic Document Analysis and Retrieval website (<U>http://www.sedarplus.ca</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may access other information
about Celestica on our website (http://www.celestica.com). Information on our website is not incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus, which constitutes
a part of the Registration Statement, does not contain all of the information set forth in the Registration Statement or the exhibits
and schedules filed with it. For further information about us, our securities and other information set forth herein, reference is made
to the Registration Statement and exhibits and schedules filed with it. Statements contained in this prospectus regarding the contents
of any contract or any other document that is filed as an exhibit to the Registration Statement are not necessarily complete, and each
such statement is subject to, and qualified in its entirety by, reference to the applicable contract or other document filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_013"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the securities
in respect of which this prospectus is being delivered will be passed upon for us by Blake, Cassels &amp; Graydon LLP with respect to
matters of Canadian law, and Skadden, Arps, Slate, Meagher &amp; Flom LLP with respect to matters of New York and U.S. federal law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_014"></A>ENFORCEABILITY OF CIVIL LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated under
the laws of the Province of Ontario, Canada. Certain experts named in this prospectus, and some of our directors and executive officers
are residents of Canada. Also, a substantial portion of our assets and the assets of these persons are located outside of the United States.
As a result, securityholders may find it difficult to effect service of process within the United States upon these persons who are not
residents of the United States, or to enforce judgments in the United States obtained in courts of the United States, because a significant
portion of our assets and the assets of these persons are located outside the United States. It may also be difficult for securityholders
to enforce a United States judgment in Canada based on the civil liability provisions of the United States federal securities laws or
the &quot;blue sky&quot; laws of any state within the United States or to succeed in a lawsuit in Canada based only on United States federal
or state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="har_015"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our consolidated financial
statements as of December 31, 2023 and 2024, and for each of the years in the three-year period ended December 31, 2024, incorporated
in this prospectus by reference to our Annual Report on Form 10-K for the year ended December 31, 2024, and the effectiveness of our internal
control over financial reporting as of December 31, 2024, have been audited by KPMG LLP, an independent registered public accounting firm,
as set forth in their reports thereon included therein, and incorporated herein by reference. Such consolidated financial statements are
incorporated herein in reliance upon the reports of KPMG LLP pertaining to such consolidated financial statements and the effectiveness
of our internal control over financial reporting, upon the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CELESTICA INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm257951d1_s3asrimg001.jpg" ALT="Celestica - Wikipedia" STYLE="height: 74px; width: 229px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFERRED SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEBT SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>March 3, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>ITEM 14.</B></TD><TD><B>Other Expenses of Issuance and Distribution</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a statement
of the estimated expenses, other than any underwriting discounts and commissions, that we expect to incur in connection with the issuance
and distribution of the securities registered under this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission registration fee</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 10%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal fees and expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accountants' fees and expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer agent and registrar fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT><FONT STYLE="font-size: 10pt">648,111.04 has been paid to the Commission and may be used to pay for securities offered pursuant to this prospectus. The payment of any additional fees has been deferred in accordance with Rule 456(b) and 457(r) of the Securities Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information regarding offering expenses is not currently known. The foregoing sets forth the general categories of expenses (other than underwriting discounts and commissions) that the Company anticipates it will incur in connection with the offering of securities under this Registration Statement. An estimate of the aggregate expenses in connection with the issuance and distribution of the securities being offered will be included in any applicable prospectus supplement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the OBCA, the registrant
may indemnify a present or former director or officer or a person who acts or acted at the registrant's request as a director or officer,
or an individual acting in a similar capacity, of another entity, against all costs, charges and expenses, including an amount paid to
settle an action or satisfy a judgment, reasonably incurred by that individual in respect of any civil, criminal, administrative, investigative
or other proceeding in which the individual is involved because of that association with the registrant or other entity; provided that
the individual acted honestly and in good faith with a view to the best interests of the registrant or, as the case may be, to the best
interests of such other entity and, in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty,
had reasonable grounds for believing that the individual's conduct was lawful. Such indemnification may be made in connection with a derivative
action only with court approval. An individual is entitled to indemnification from the registrant as a matter of right if the individual
was not judged by a court or other competent authority to have committed any fault or omitted to do anything that the individual ought
to have done and the individual fulfilled the conditions set forth above. Under such Act, the registrant may advance money to a director,
officer or other individual for the costs, charges and expenses of a proceeding referred to above, but the individual must repay the money
if the individual does not fulfil the conditions set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with and subject
to the OBCA, the by-laws of the registrant provide for indemnification of a director or officer of the registrant, a former director or
officer of the registrant, or a person who acts or acted at the registrant's request as a director or officer, or an individual acting
in a similar capacity, of another entity, and his heirs and legal representatives, against all costs, charges and expenses, including
an amount paid to settle an action or satisfy a judgment, reasonably incurred by him in respect of any civil, criminal, administrative,
investigative or other proceeding in which the individual is involved because of that association with the registrant or other entity,
if he acted honestly and in good faith with a view to the best interests of the registrant or, as the case may be, to the best interests
of the other entity for which he acted as a director or officer or in a similar capacity at the registrant's request. Also, the by-laws
provide that the registrant may advance money to a director, officer or other person for the costs, charges and expenses of a proceeding
referred to above, but the person shall repay the money if the person does not fulfil the conditions set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The directors and officers
of the registrant are covered by directors' and officers' insurance policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to Item
17 for the undertakings of the registrant with respect to indemnification for liabilities arising under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B>ITEM 16. EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) EXHIBITS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exhibits have been filed as part
of this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT<BR>
NUMBER</B></FONT></TD>
    <TD STYLE="padding: 0.25pt 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriting Agreement</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924051983/tm2411572d2_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924051983/tm2411572d2_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Common Share Certificate</FONT> <FONT STYLE="font-size: 10pt">(1)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924051983/tm2411572d2_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924051983/tm2411572d2_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate and Restated Articles of Incorporation effective April 25, 2024</FONT> <FONT STYLE="font-size: 10pt"><U>(1)</U></FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924051983/tm2411572d2_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924051983/tm2411572d2_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate and Articles of Amendment, effective April 25, 2024 (1)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924028621/tm247401d1_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465924028621/tm247401d1_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated By-law 1</FONT> <FONT STYLE="font-size: 10pt">(2)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465925007666/tm254558d1_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465925007666/tm254558d1_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By-law No. 2 (3)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Preferred Share Certificate</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465917064049/a17-22993_1ex4d6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1030894/000110465917064049/a17-22993_1ex4d6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indenture (4)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Blake, Cassels &amp; Graydon LLP </FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Skadden, Arps, Slate, Meagher &amp; Flom LLP</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of KPMG LLP, Chartered Professional Accountants, Licensed Public Accountants</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Blake, Cassels &amp; Graydon LLP (contained in opinion filed as Exhibit 5.1)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="tm257951d1_ex5-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Skadden, Arps, Slate, Meagher &amp; Flom LLP (contained in opinion filed as Exhibit 5.2)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt 0.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.25pt; padding-right: 0.75pt; padding-left: 0.75pt"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers of Attorney (included in signature page hereto)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1**</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T-1 Statement of Eligibility and Qualification of Trustee</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm257951d1_ex-filingfees.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="tm257951d1_ex-filingfees.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To be filed by amendment or by a Current Report on Form 8-K incorporated herein by reference.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To be filed in accordance with the requirements of Section 305(b)(2) of the Trust Indenture Act of 1939 and Rule 5b-3 thereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Incorporated by reference to the Registrant's Report on Form 6-K (File No. 001-14832) furnished to the Commission on April 25, 2024.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Incorporated by reference to Registrant's Report on Form 6-K (File No. 001-14832) furnished to the Commission on February 28, 2024.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Incorporated by reference to Registrant's Report on Form 8-K (File No. 001-14832) filed with the Commission on January 31, 2025.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(4)&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Incorporated by reference to Registration Statement on Form F-3 (File No. 333-221144) filed on October 26, 2017.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B>ITEM 17. UNDERTAKINGS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="text-align: justify">To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 0.25in; text-align: left">i.</TD><TD STYLE="text-align: justify">to include any prospectus required by Section 10(a)(3) of the
Securities Act;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify">to reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b), if, in the aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the &quot;Calculation of Filing Fee Tables&quot; or &quot;Calculation of
Registration Fee&quot; table, as applicable, in the effective registration statement; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">iii.</FONT></TD><TD STYLE="text-align: justify">to include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided,
however</I></FONT>, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included
in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant
pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration
statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="text-align: justify">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: justify">To remove from registration by means of a post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)</FONT></TD><TD STYLE="text-align: justify">N/A</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD><TD STYLE="text-align: justify">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 0.25in; text-align: left">i.</TD><TD STYLE="text-align: justify">Each prospectus filed by the registrant pursuant to Rule 424(b)(3)
shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration
statement; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">ii.</FONT></TD><TD STYLE="text-align: justify">Each prospectus required to be filed pursuant to Rule 424(b)(2),
(b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i),
(vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to
be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness
or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability
purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of
such securities at that time shall be deemed to be the initial bona fide offering thereof. <I>Provided, however</I>, that no statement
made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser
with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6)</FONT></TD><TD STYLE="text-align: justify">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any
purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities
of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities
to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned
registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">(i) Any preliminary prospectus or prospectus
of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">(ii) Any free writing prospectus relating
to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">(iii) The portion of any other free
writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">(iv) Any other communication that is
an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify">The undersigned registrant hereby undertakes that, for purposes
of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a)
or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report
pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall
be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT> &ndash; (g) &nbsp;&nbsp;&nbsp;&#9;N/A</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)</FONT></TD><TD STYLE="text-align: justify">Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions,
or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against
public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Act and will be governed by the final adjudication of such issue.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">N/A</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)</FONT></TD><TD STYLE="text-align: justify">The undersigned registrant hereby undertakes to file an application
for the purpose of determining the eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act (&quot;Act&quot;)
in accordance with the rules and regulations prescribed by the Commission under section 305(b)(2) of the Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)</FONT></TD><TD STYLE="text-align: justify">N/A</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Burlington, Province of Ontario, Country of Canada, on the 3<SUP>rd</SUP> day of March, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">CELESTICA INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: left">/s/ Douglas Parker</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Douglas Parker</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Legal Officer and Corporate Secretary&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each person whose signature
appears below hereby authorizes and appoints Robert A. Mionis, Mandeep Chawla and/or Douglas Parker and each of them, any of whom may
act without the joinder of any other, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution,
for him or her and in his or her name, place and stead, to sign and file on his or her behalf, individually and in any capacity, any amendments
and post-effective amendments to this registration statement, with exhibits thereto, and all other documents in connection therewith,
including registration statements filed in connection with this offering pursuant to Rule 462(b) under the Securities Act, with the Commission,
granting unto said attorneys-in-fact and agents full power and authority to do everything necessary to accomplish the foregoing, as fully
to all intents and purposes as he or she might or could do in person, and each of the undersigned does hereby ratify and confirm all that
each of said attorneys-in-fact and agents, or their substitutes, shall do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates
indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATE</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert A. Mionis</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, President and Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert A. Mionis</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mandeep Chawla</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mandeep Chawla</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer and Principal Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael M. Wilson</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair of the Board and Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael M. Wilson</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kulvinder (Kelly) Ahuja</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kulvinder (Kelly) Ahuja</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert A. Cascella&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert A. Cascella</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <FONT STYLE="background-color: white">Fran&ccedil;oise </FONT>Colpron&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fran&ccedil;oise </FONT><FONT STYLE="font-size: 10pt">Colpron</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jill Kale&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill Kale</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Amar Maletira </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amar Maletira</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Luis A. <FONT STYLE="background-color: white">M&uuml;ller</FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luis A. <FONT>M&uuml;ller</FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AUTHORIZED REPRESENTATIVE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of Section 6(a) of the Securities Act, the undersigned has signed this Registration Statement, solely in the capacity of the duly authorized
representative of Celestica Inc. in the United States, on the 3<SUP>rd</SUP> day of March, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Celestica Inc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(Authorized U.S. Representative)</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: left">/s/ Robert A. Mionis</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Robert A. Mionis</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">President and Chief Executive Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm257951d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; vertical-align: middle; font-size: 10pt"><IMG SRC="tm257951d1_ex5-1img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: right">&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;<IMG SRC="tm257951d1_ex5-1img002.jpg" ALT=""></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celestica Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5140 Yonge Street, Suite&nbsp;1900</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Toronto, Ontario</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada M2N 6L7</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celestica Inc.</FONT></TD></TR>

<TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="text-align: justify">Registration Statement on Form&nbsp;S-3</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sirs/Mesdames:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as Canadian counsel to Celestica
Inc. (the &ldquo;Company&rdquo;) in connection with the Registration Statement on Form&nbsp;S-3 (the &ldquo;Registration Statement&rdquo;)
filed on March&nbsp;3, 2025 by the Company with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under the U.S.
Securities Act of 1933, as amended (the &ldquo;Act&rdquo;), relating to the registration by the Company for its issue and sale from time
to time of, among other securities, common shares (the &ldquo;Common Shares&rdquo;) and preference shares (the &ldquo;Preference Shares&rdquo;
and together with the Common Shares, the &ldquo;Securities&rdquo;) in its capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is being provided at the request
of the Company. As Canadian counsel for the Company, we have examined a copy of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are solicitors qualified to practice law in
the Province of Ontario and the opinions expressed herein relate only to the laws of the Province of Ontario and the laws of Canada applicable
therein as in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the opinions expressed in this
opinion letter, we have considered such questions of law, examined originals or copies of such statutes, regulations, documents, records,
certificates and instruments and conducted such other examinations as we have considered necessary. In such examinations, we have assumed
the legal capacity of all individuals, the genuineness of all signatures, the authenticity of all documents submitted to us as originals
and the conformity to authentic original documents of all documents submitted to us as certified, conformed, photostatic or facsimile
copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have also assumed that at all relevant times:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company is validly existing under the <I>Business Corporations Act</I> (Ontario) and has the necessary corporate power and capacity to own its property and assets and to carry on its business;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company has the necessary corporate power and capacity to execute, deliver and perform its obligations under the terms and conditions of any purchase, underwriting or other agreement, indenture or instrument relating to the Company&rsquo;s creation, authentication, issuance, sale and/or delivery of the Securities to which the Company is party (any such agreement, the &ldquo;Agreement&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company has the necessary corporate power and capacity to authorize, create, authenticate, validly issue, sell and deliver the Securities and perform its obligations under the terms and conditions of the Securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all necessary corporate action has been taken by the Company to duly authorize the execution and delivery by the Company of the Agreement and the performance of its obligations under the terms and conditions thereof;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm257951d1_ex5-1img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><IMG SRC="tm257951d1_ex5-1img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page&nbsp;2</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all necessary corporate action has been taken by the Company to duly authorize, create, authenticate, sell, deliver and validly issue the Securities and to perform its obligations under the terms and conditions of the Securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="padding-left: 28.55pt; font-size: 10pt; text-align: justify; text-indent: -28.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all necessary corporate action has been taken by the Company to duly authorize the terms of the offering of the Securities and related matters;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Agreement (i)&nbsp;has been duly authorized, executed and delivered by all parties thereto and such parties had the capacity to do so; (ii)&nbsp;constitutes a legal, valid and binding obligation of all parties thereto; and (iii)&nbsp;is enforceable in accordance with its terms against all parties thereto;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Securities have been duly authorized, created, authenticated, sold and delivered and validly issued by the Company and any other person signing or authenticating the Securities, as applicable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="padding-left: 27.85pt; font-size: 10pt; text-align: justify; text-indent: -27.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms of the offering of the Securities and related matters have been duly authorized by the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the execution and delivery of the Agreement and the performance by the Company of its obligations under the terms and conditions thereunder do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the authorization, creation, authentication, sale, delivery and issuance of the Securities and the Company&rsquo;s performance of its obligations under the terms and conditions of the Securities do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms of the offering of the Securities and related matters do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing, and subject to the qualifications,
assumptions and limitations stated herein, we are of the opinion that, upon payment for the applicable Securities provided for in the
applicable Agreement and otherwise in accordance with such Agreement, the Securities will be validly issued, fully paid and non-assessable
shares in the capital of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
letter as Exhibit&nbsp;5.1 to the Registration Statement and to the use of our name under the caption &ldquo;Legal Matters&rdquo; in the
Prospectus included in the Registration Statement. In giving this opinion, we do not thereby admit that we are within the category of
persons whose consent is required under Section&nbsp;7 of the U.S. Securities Act of 1933 or the rules&nbsp;and regulations of the U.S.
Securities and Exchange Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
very truly,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">/s/ Blake, Cassels&nbsp;&amp; Graydon LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm257951d1_ex5-1img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>tm257951d1_ex5-2.htm
<DESCRIPTION>EXHIBIT 5.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%; text-align: center"><FONT STYLE="font-size: 13pt; font-variant: small-caps">Skadden, Arps, Slate, Meagher&nbsp;&amp;
    Flom llp</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; text-transform: uppercase">One Manhattan West</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">FIRM/AFFILIATE</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; text-transform: uppercase">New York, NY 10001</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">OFFICES</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt; text-transform: uppercase">________</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">-----------</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">TEL: (212) 735-3000</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">BOSTON</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">FAX: (212) 735-2000</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">CHICAGO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">www.skadden.com</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">HOUSTON</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">LOS ANGELES</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">PALO ALTO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">WASHINGTON, D.C.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">WILMINGTON</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">-----------</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">ABU DHABI</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">BEIJING</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">BRUSSELS</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">FRANKFURT</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">HONG KONG</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">LONDON</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">MUNICH</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">PARIS</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">S&Atilde;O PAULO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">SEOUL</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">SINGAPORE</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">TOKYO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">TORONTO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5in 0pt 0; text-align: right">March&nbsp;3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Celestica Inc.<BR>
5140 Yonge Street, Suite&nbsp;1900<BR>
Toronto, Ontario<BR>
Canada M2N 6L7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD>Celestica Inc.<BR>
                                            <U>Registration Statement on Form&nbsp;S-3</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have acted as special United States counsel to
Celestica Inc., a corporation organized under the laws of Ontario (the &ldquo;Company&rdquo;), in connection with the registration statement
on Form&nbsp;S-3 (the &ldquo;Registration Statement&rdquo;) to be filed on the date hereof by the Company with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) under the Securities Act of 1933 (the &ldquo;Securities Act&rdquo;). The Registration Statement
relates to the issuance and sale by the Company from time to time, pursuant to Rule&nbsp;415 of the General Rules&nbsp;and Regulations
of the Commission promulgated under the Securities Act (the &ldquo;Rules&nbsp;and Regulations&rdquo;), of debt securities of the Company
(&ldquo;Debt Securities&rdquo;), which may be issued in one or more series under an indenture (the &ldquo;Indenture&rdquo;) proposed
to be entered into by the Company and the trustee to be named therein, the form of which is filed as an exhibit to the Registration Statement,
and other securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This opinion is being furnished in accordance with
the requirements of Item 601(b)(5)&nbsp;of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In rendering the opinion stated herein, we have
examined and relied upon the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Registration Statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
form of Indenture filed as an exhibit to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have also examined originals or copies, certified
or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and receipts of public
officials, certificates of officers or other representatives of the Company and others, and such other documents as we have deemed necessary
or appropriate as a basis for the opinion stated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Celestica Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;2</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In our examination, we have assumed the genuineness
of all signatures, including electronic signatures, the legal capacity and competency of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic,
certified or photocopied copies, and the authenticity of the originals of such copies. As to any facts relevant to the opinion stated
herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives
of the Company and others and of public officials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We do not express any opinion with respect to the
laws of any jurisdiction other than the laws of the State of New York (&ldquo;Opined-on Law&rdquo;). We do not express any opinion as
to the effect of any non-Opined-on Law on the opinion stated herein. The Debt Securities may be issued from time to time on a delayed
or continuous basis, and this opinion is limited to the laws, including the rules&nbsp;and regulations, as in effect on the date hereof,
which laws are subject to change with possible retroactive effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">As used herein &ldquo;Transaction Documents&rdquo;
means the Indenture and the supplemental indentures thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The opinion stated in paragraph 1 below presumes
that all of the following (collectively, the &ldquo;general conditions&rdquo;) shall have occurred prior to the issuance of any series
of Debt Securities referred to therein: (i)&nbsp;the Registration Statement, as finally amended (including all necessary post-effective
amendments), has become effective under the Securities Act; (ii)&nbsp;an appropriate prospectus supplement or term sheet with respect
to such Debt Securities has been prepared, delivered and filed in compliance with the Securities Act and the applicable Rules&nbsp;and
Regulations; (iii)&nbsp;the applicable Transaction Documents shall have been duly authorized, executed and delivered by the Company and
the other parties thereto, including, if such Debt Securities are to be sold or otherwise distributed pursuant to a firm commitment underwritten
offering, the underwriting agreement or purchase agreement with respect thereto; (iv)&nbsp;the Board of Directors of the Company, including
any duly authorized committee thereof, shall have taken all necessary corporate action to approve the issuance and sale of such Debt
Securities and related matters and appropriate officers of the Company have taken all related action as directed by or under the direction
of the Board of Directors of the Company; and (v)&nbsp;the terms of the applicable Transaction Documents and the issuance and sale of
such Debt Securities have been duly established in conformity with the articles of incorporation of the Company so as not to violate
any applicable law, the articles of incorporation of the Company or the bylaws of the Company, or result in a default under or breach
of any agreement or instrument binding upon the Company or its properties, and so as to comply with any requirement or restriction imposed
by any court or governmental body having jurisdiction over the Company or its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Based upon the foregoing and subject to the qualifications
and assumptions stated herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;With
respect to any series of Debt Securities offered by the Company, including such indeterminate amount of Debt Securities as may be issued
upon conversion or exchange of such series (the &ldquo;Offered Debt Securities&rdquo;), when (a)&nbsp;the general conditions shall have
been satisfied, (b)&nbsp;the Indenture has been qualified under the Trust Indenture Act of 1939, (c)&nbsp;the issuance, sale and terms
of the Offered Debt Securities and related matters have been approved and established in conformity with the applicable Transaction Documents
and (d)&nbsp;the certificates evidencing the Offered Debt Securities have been issued in a form that complies with the provisions of
the applicable Transaction Documents and have been duly executed and authenticated in accordance with the provisions of the Indenture
and any other applicable Transaction Documents and issued and sold or otherwise distributed in accordance with the provisions of the
applicable Transaction Document upon payment of the agreed-upon consideration therefor, the Offered Debt Securities will constitute valid
and binding obligations of the Company, enforceable against the Company in accordance with their respective terms under the laws of the
State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The opinion stated herein is subject to the following
qualifications:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
do not express any opinion with respect to the effect on the opinion stated herein of any bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer, preference and other similar laws or governmental orders affecting creditors&rsquo; rights generally, and the opinion
stated herein is limited by such laws and governmental orders and by general principles of equity (regardless of whether enforcement
is sought in equity or at law);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Celestica Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
do not express any opinion with respect to any law, rule&nbsp;or regulation that is applicable to any party to any of the Transaction
Documents or the transactions contemplated thereby solely because such law, rule&nbsp;or regulation is part of a regulatory regime applicable
to any such party or any of its affiliates as a result of the specific assets or business operations of such party or such affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;except
to the extent expressly stated in the opinion contained herein, we have assumed that each of the Transaction Documents constitutes the
valid and binding obligation of each party to such Transaction Document, enforceable against such party in accordance with its terms;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
do not express any opinion with respect to the enforceability of any provision contained in any Transaction Document relating to any
indemnification, contribution, non-reliance, exculpation, release, limitation or exclusion of remedies, waiver or other provisions having
similar effect that may be contrary to public policy or violative of federal or state securities laws, rules&nbsp;or regulations, or
to the extent any such provision purports to, or has the effect of, waiving or altering any statute of limitations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
do not express any opinion with respect to the enforceability of any provision of any Transaction Document to the extent that such section
purports to bind the Company to the exclusive jurisdiction of any particular federal court or courts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
call to your attention that irrespective of the agreement of the parties to any Transaction Document, a court may decline to hear a case
on grounds of forum non conveniens or other doctrine limiting the availability of such court as a forum for resolution of disputes; in
addition, we call to your attention that we do not express any opinion with respect to the subject matter jurisdiction of the federal
courts of the United States of America in any action arising out of or relating to any Transaction Document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
opinion stated herein is limited to the agreements and documents specifically identified in the opinion contained herein (the &ldquo;Specified
Documents&rdquo;) without regard to any agreement or other document referenced in any such Specified Document (including agreements or
other documents incorporated by reference or attached or annexed thereto) and without regard to any other agreement or document relating
to any such Specified Document that is not a Transaction Document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
have assumed that any agent of service will have accepted appointment as agent to receive service of process and call to your attention
that we do not express any opinion if and to the extent such agent shall resign such appointment. Further, we do not express any opinion
with respect to the irrevocability of the designation of such agent to receive service of process;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;subsequent
to the effectiveness of the Indenture and immediately prior to the issuance of any series Offered Debt Securities, the Indenture has
not been amended, restated, supplemented or otherwise modified in any way that affects or relates to such series of Offered Debt Securities
other than by the applicable Transaction Documents relating to such series of Offered Debt Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;this
opinion letter shall be interpreted in accordance with customary practice of United States lawyers who regularly give opinions in transactions
of this type;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
have assumed that the choice of New York law to govern any Transaction Documents and that such choice is and will be a valid and legal
provision;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
have assumed that the Indenture will be duly authorized, executed and delivered by the trustee in substantially the form reviewed by
us;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xiii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
call to your attention that the opinion stated herein is subject to possible judicial action giving effect to governmental actions or
laws of jurisdictions other than those with respect to which we express our opinion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Celestica Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;4</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xiv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;we
do not express any opinion with respect to the enforceability of any provision contained in any Transaction Document providing for indemnity
by any party thereto against any loss in obtaining the currency due to such party under any Transaction Document from a court judgment
in another currency; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the extent that any opinion relates to the enforceability of the choice of New York law and choice of New York forum provisions contained
in any Transaction Document, the opinion stated herein is subject to the qualification that such enforceability may be subject to, in
each case, (i)&nbsp;the exceptions and limitations in New York General Obligations Law sections 5-1401 and 5-1402 and (ii)&nbsp;principles
of comity and constitutionality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In addition, in rendering the foregoing opinion
we have also assumed that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Company (i)&nbsp;is duly incorporated and is validly existing and in good standing, (ii)&nbsp;has requisite legal status and legal capacity
under the laws of the jurisdiction of its organization and (iii)&nbsp;has complied and will comply with all aspects of the laws of the
jurisdiction of its organization in connection with the transactions contemplated by, and the performance of its obligations under, the
Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Company has the corporate power and authority to execute, deliver and perform all its obligations under each of the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;neither
the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its obligations thereunder,
including the issuance and sale of the applicable Debt Securities: (i)&nbsp;conflicts or will conflict with the articles of incorporation
and bylaws of the Company, (ii)&nbsp;constitutes or will constitute a violation of, or a default under, any lease, indenture, agreement
or other instrument to which the Company or its property is subject, (iii)&nbsp;contravened or will contravene any order or decree of
any governmental authority to which the Company or its property is subject, or (iv)&nbsp;violates or will violate any law, rule&nbsp;or
regulation to which the Company or its property is subject (except that we do not make the assumption set forth in this clause (iv)&nbsp;with
respect to the Opined-on Law); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;neither
the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its obligations thereunder,
including the issuance and sale of the applicable Debt Securities, requires or will require the consent, approval, licensing or authorization
of, or any filing, recording or registration with, any governmental authority under any law, rule&nbsp;or regulation of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We hereby consent to the reference to our firm under
the heading &ldquo;Legal Matters&rdquo; in the prospectus forming part of the Registration Statement. We also hereby consent to the filing
of this opinion with the Commission as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that
we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the Rules&nbsp;and Regulations.
This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking to advise you of any
subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom
    LLP</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RJD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>tm257951d1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors<BR>
Celestica Inc.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">We consent to the use of our report dated
February&nbsp;28, 2025, on the consolidated financial statements of Celestica Inc. (the &ldquo;Company&rdquo;), which comprise the consolidated
balance sheets as of December&nbsp;31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, changes
in equity and cash flows for each of the years in the three-year period ended December&nbsp;31, 2024, and the related </FONT>notes, and
our report dated February&nbsp;28, 2025 on the effectiveness of the Company&rsquo;s internal control over financial reporting as of December&nbsp;31,
2024, which are incorporated by reference, and to the reference to our firm under the heading &ldquo;Experts&rdquo; in the prospectus
included in the Registration Statement on Form&nbsp;S-3 dated March&nbsp;3, 2025 of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ KPMG LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chartered Professional Accountants, Licensed Public Accountants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Toronto, Canada</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>tm257951d1_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-365">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-366">S-3ASR</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-367">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-368">0001030894</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-369">CELESTICA INC</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_2">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_3">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_4">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_5">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_6">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_7">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_8">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001030894</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-03-03</xbrli:startDate>
              <xbrli:endDate>2025-03-03</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-457">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-458">CELESTICA INC</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word">
            <p style="margin: 0pt; text-align: center;">
              <b>Table 1: Newly Registered and Carry Forward Securities</b>
            </p>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-459">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-460">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-461">Common shares, without par value</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-462">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-463">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_2" format="ixt:booleanfalse" id="ixv-464">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		2
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-465">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-466">Preferred shares, without par value</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-467">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-468">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_3" format="ixt:booleanfalse" id="ixv-469">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		3
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_3" id="ixv-470">Debt</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_3" id="ixv-471">Debt securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_3" format="ixt:booleantrue" id="ixv-472">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-473">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_4" format="ixt:booleanfalse" id="ixv-474">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		4
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_4" id="ixv-475">Other</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_4" id="ixv-476">Warrants to purchase common shares, preferred shares, debt securities or other securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_4" format="ixt:booleantrue" id="ixv-477">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-478">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">
		5
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_5" id="ixv-479">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_5" id="ixv-480">	 Common shares, without par value</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_5" format="ixt:booleantrue" id="ixv-481">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-482">643,337,715.93</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_5" id="ixv-483">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_5" id="ixv-484">333-273467</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_5" id="ixv-485">07/27/2023</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-486">162,027.76</ix:nonFraction>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">
		6
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_6" id="ixv-487">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_6" id="ixv-488">Preferred shares, without par value</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_6" format="ixt:booleantrue" id="ixv-489">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-490">643,337,715.93</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_6" id="ixv-491">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_6" id="ixv-492">333-273467</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_6" id="ixv-493">07/27/2023</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-494">162,027.76</ix:nonFraction>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">
		7
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_7" id="ixv-495">Debt</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_7" id="ixv-496">Debt securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_7" format="ixt:booleantrue" id="ixv-497">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-498">643,337,715.93</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_7" id="ixv-499">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_7" id="ixv-500">333-273467</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_7" id="ixv-501">07/27/2023</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-502">162,027.76</ix:nonFraction>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">
		8
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_8" id="ixv-503">Other</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_8" id="ixv-504">Warrants to purchase common shares, preferred shares, debt securities or other securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_8" format="ixt:booleantrue" id="ixv-505">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-506">643,337,715.93</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_8" id="ixv-507">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_8" id="ixv-508">333-273467</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_8" id="ixv-509">07/27/2023</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-510">162,027.76</ix:nonFraction>
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-511">2,573,350,863.72</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-512">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-513">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-514">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-515">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-516">An indeterminate aggregate initial offering price or principal amount or number of securities of each identified class is being registered as may from time to time be offered at indeterminate prices and as may from time to time be issued upon conversion, redemption, exchange, exercise or settlement of any securities registered hereunder, including under any applicable anti-dilution provisions.

In accordance with Rules 456(b) and 457(r) under the Securities Act, the Registrant is deferring payments of all of the registration fees (except with respect to the carry forward securities identified in the "Carry Forward Securities" table above and footnote 5 below, with respect to which registration fees have already been paid). Any subsequent registration fees will be paid on a pay-as-you-go basis based on the fee rate in effect on the date of such fee payment.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">2</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_2" id="ixv-517">See footnote 1.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">3</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_3" id="ixv-518">See footnote 1.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">4</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_4" id="ixv-519">See footnote 1.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">5</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_5" id="ixv-520">Pursuant to Rule 415(a)(6) of the Securities Act, this Registration Statement includes and carries forward $2,573,350,863.72 of unsold common shares, preferred shares, debt securities and warrants to purchase common shares, preferred shares, debt securities or other securities ("Unsold Securities") that were previously registered by the Registrant pursuant to its registration statement on Form F-3 (File No. 333-273467) with the Securities and Exchange Commission on July 27, 2023 (the "2023 Registration Statement"); filing fees of $648,111.04 have already been paid with respect to such unsold securities ("Unutilized Fees"). In accordance with Rule 415(a)(6) of the Securities Act, the Unutilized Fees will continue to be applied to such Unsold Securities and are being carried forward to this Registration Statement. The effectiveness of this Registration Statement will be deemed to terminate the 2023 Registration Statement.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">6</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_6" id="ixv-521">See footnote 5.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">7</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_7" id="ixv-522">See footnote 5.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">8</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_8" id="ixv-523">See footnote 5.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm257951d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257951d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !& .P# 2(  A$! Q$!_\0
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M;7Q1\1+$R23JIL/B?\3?AKK%M*%@U+3[*YE@AF_FE_8S_P"#FO\ X*4?&?\
MX*>>!_V)M;^'_P"Q_P#'OP'XS_:+U3X)S^*/V>?!GQ;T.#6?#&C>+=4T._\
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M\%^!=3UDS:1H?Q6A75O WQ1U+4K+1C#;W,L6M>/[9IX[DV^H2K($;PG]E_\
MX,SOBQ\0M;@^(W_!1?\ ;4:75M4G;4=<\'_ FTUKQKXWU)90A66]^-OQ6M-+
M&D:K'P&LV^%WBVT5MVR]5D8, ?K]^T[_ ,':W_!)OX(1WVE_"WQ3\5?VJ/%*
M1&VMU^$?PZO_  YX475T8+'_ &GXU^+%]\,X9M,P"3JWA*P\46( VI,5(V?%
MOA;_ (+(?\'!'_!2YDM/^";W_!-3PQ^S7\*O$$:&Q_:"_:*EU+7K.STYN(O$
MGA?Q;\0K'X8>!=:A(4;[71OAC\7;C>0J6C88K^[_ .QU_P $)O\ @E_^P[+I
M&M?!G]ESP/K/Q!TEDE3XL_%U+SXM_$=[M3SJ>G:QXTN-1L?".J.N%:?P-IGA
MFQSN8::&;C]:=T&P  [ I$?F<Q(L;/ ZL0%+JKX+K<2>1+E7AF8*64 _E:\'
M_P#!O]^US^U64U__ (+(_P#!5#]H#]I.TU&:.]UK]FG]GWQ)JWPK_9[34YE$
M7V&Y,>G:-8:MI[2-$2N@_"?X=W#1A3%*44R-_-Q_P75_;D_8T_9>T7Q?_P $
ML?\ @DG\)?AA\%_ .CR2^%?VN_CQ\,M*7_A*_B=K.CRVGVKX%VOQ7O9=0\>>
M,?#NC:G:P'XH:IKWC#Q!IVHZO:VGABSO9+6QU<:U^^O_  <N_P#!=BU_8O\
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M+4(!=Z%X2L+R%XKWQ*]KIGB7QRT-MJ&NV.EV$&C>%O#WT7_P3HN?^"0'[/\
M\/M&_9U_X)V_&O\ 8VU#389OMU]HWPD^._PM^(_Q"\;>(S;$MXN\=:CH7B_6
M_$OBSQ'=6%I.MOK6LK<?V?8AM-T2+3-&CBTB/]!_B9\;?#?PO_L^WO\ PO\
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M)?PH,LCQ:-INFZ1%8'Q=-8R1ZGX7\'WD_B[5I9O''Q!T'Q-JH!Z+_P $B?\
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M/K-]"RB/4-3GCT70O#J/$_BCQ1HEO()T /PD_P""L7_!$+_@EK\/_P#@G?\
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M$;U)/&>IZ#"+GXZ^-+NXMM0T>/Y9_80\(Z1_P5)_X.$[#]M[]C[X3Z)\&_\
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M35?"'@8^&$TEC:? _P"#?]J7L?P_\-:IXJ9_B3)_2O\ L<_\$]_&?AKXF_\
M#<'[>GQ$T;]I+]NWQ#I][9Z5J>@:;<P_ O\ 99\*:Q;K:W/PM_94\(S6\EUH
M=A:Z<C:/K_Q2NH-/^('Q/B7^U?%_DWDL\#?S1?\ ![K\2'L_ '_!/_X,6LP\
MK6?%_P <?B/K&GQ+-%%;1^&=#^'WA7PC)<11R31W+D^+/&<<4D+;X?LTX1,/
ME@#]=?\ @U#^"FC?#+_@CK\&O&%MI=I;>(/CS\0_C#\5O%U\T3?:=1O(/'U[
M\.O#\LK.J27>WPCX$T9X9I9?+T^>:X6QBDCN[AY/Z53*JKN<%% R[.55(QZL
MY;9@=]K-BOXQ_P#@G#_P7\_X)N?L4_\ !-[]B7]E[0]7^-/[2_[1?@_X&^&M
M+\5?!/\ 9E^"7BWQSXITKQUJ]N_B37=#.K>)D\"^!-:U"QUK69;#4+?PSXQU
MRXCOR419(Y(II/K^;_@JU_P6V_:+CW?L6?\ !#3Q5\.=(O/DT[XC_MR?%W1?
MAE) BJ2S:W\)]3E^&7BR # "QV/B_4)&) "\4 ?T]EQZ.3Z!'Y]LD #\2!ZF
MF-.BL58."%+EC'((P ,G,Y40 ^QD'-?RT7?[-W_!U7\?Y3<^-?V[?V"?V+M!
MU''VOPS\ _A?>_$3Q)I@'*@7/Q ^&WB>=2X)R;;XHNV,C<#MSQ6I?\&[?_!1
M#XM/]J_:-_X.#?VU/%D=XO\ Q,?#/PZT3QK\/_#D;#/_ !Y65E^T&?#I!XR7
M\%P@=D]0#^LQIT0C=D!AE6&&WL%+[(U4F25]@+8B1Q@'G((IANHAC.<D9(!0
M[3D@J2KE2RD%6VLP!! )Q7\B6F?\&?G[,=UKECXJ\>?M]_M^>)_%UC<?:XO$
MVD^._ 6@ZM;S<\Z;J&L^!_&.K:=C/$B:K-+T&X;0:_;G]G[_ ()M>(OV<OAY
M;_#/PU_P4-_X**_$/0[+4KG4-.U;XU?&?X1?$OQ7IEO<VMC;)H%AXAUG]G@W
MT'AK3OL6_2-'+R6^FFYNDM?*MI(K:  _3VN#^)7Q.\!_!WX?>-?BK\4/$^E>
M!_AU\._#>J^+O&7B_7[F.RT?0O#VBV37^H:C=S,Q?;% CK';)&]Y<W 2VMK>
M6>XM8Y^\K^<3_@OO^P/_ ,%*O^"EW@?X2_LK?LD>./@C\-?V9]8U)O%/[27B
M7X@^./$^A^(O$>NZ9J4<OACP]<Z1H'@KQ1+J/@O0XXO^$DDLK&[\W5_$1TRR
MO;:VTS0X;F[ /X]?VEOC-^U9_P '1/\ P51\(_!7X)V^M>%/V;_ 5YJUK\.-
M/UJSNY?#?P=^!=KJ-K'XP_:#^)=C$$2;Q[XLM9=/U*UTO5)X&UR\N/"_PQTF
M_P"3J.K_ +Z?MT?\%0/AK_P1Y\#?"#_@BE_P1N^&%I\4_P!KNQMM!^'JWEII
M]MXSD^'_ (X\8_V?>+K7B2S5$L_B'^T5XZO]63QQ=Q:A ? 7@H7]NOB31KK1
M](@\'V'[H?\ !'S_ () _!__ ())?L[/\+O!^K67Q'^+GCN\L?$7QR^-5WX?
M&BWWCG7],:;^P='T72I+_5KK0_!/@Z"[O(_"VC7.LZB+75-1\2^)&CCOO%NH
M6EI^$(_X-S/^"B'[.'_!5W7/^"E'[(GQ_P#V1?C"U_\ &7XN?%K3/"?[7]]\
M:= UB%/C)%XQL]<\/>(;OX=^ ?B$GB.\T'2O&FIZ9HWBN/5-%O9DBM+@Z;IQ
MMXH$ /OK_@E+_P $&]#^ 7C"#]N#_@HOXHG_ &O_ /@HWXUU'1_'%_XO^)%P
M?%W@[X(Z[<QK)9:;X"&JQR:3XE\<^'W@6-?'PMK<>'C;:=%\/_#_ (6&FVU]
MJ_\ 1%X_^(?@#X4^#]>^(?Q0\;^%_ASX"\+69OO$7C#QWXBTKPSX8T#38U)%
M_KNO:[>Z9:V5L=^)(M1O22[HH3<RU^8NL?#_ /X+@_%"T&D7GQW_ ."='[)5
MI=QR)?>*/@_\(_CM^T_XXL9)P!+=Z+_PMGQ5\$? ;SI@&(:]X(UE ?F)4YSX
M;#_P;_? +XQ>*=)^(O\ P45_:/\ VI_^"D?CC1[IM2TG0/CK\2+CP3\ ?"FI
M.DD;R_#[X!?"5/"OAOPC9NDC))ITNKZ[;2+@2*^WD ^(/VK/^#CK7OC!XSU/
M]E__ ((D_LW^/OV[_P!H"=IM-UCXQ0^"?$\7P!^&D\HN(TU>Y?5+;P\NM0Q7
M$(\W7_%=_P##WX=*)5GC\7ZE S+7S/\ LR?\&R7QU_:W^,4/[8G_  72_:0\
M0_'+XH:LEG>-^SOX$\3M-HVE:7I[/-IO@SQMXZT:+3+?1_"-N)7-O\-?@=IO
MAS3=-+-)9?$*ZEEN(V_L/^$?P-^#WP"\%V/PX^!_PJ^'/P=\ :8KG3_!GPO\
M&Z#X%\-VEQ(")+J#2/"]AI&GQ7,@)\VY2T6[D8[WN"U>FK;X&TA#&K@Q1_NP
MD8&?WL?EP1M'*2S<!F ZJXW' !^+'_!2+]N/]E__ ((:?L&'4/AY\/\ X>>%
M]1TRUNO '[*W[.O@_1K;P_I.O_$6XM&;2]_A_3'AOCX;T*-_^$E^)/B6UGLK
M^]BN?])U*/Q7XUT26]_SFO\ @FSK/PH_:O\ ^"B.N_M8_P#!0'4OB9^TOX^/
MC6T^*FB_LT?#CPEJOQ*^-'[8'[0.NZW/?^%_!6D:39Q1>$/#OPFT672UOO%&
MH^*-;\*^#O"W@^P\.>%;-Y=&GM[B;^J+_@K9_P &]W_!4+_@J[_P4"\3?%_Q
MG^TG^SEX._9B\/0V?A'X$:9J.M?$C5]?^&WPO,27&I11?#NQ^'$'A[6/&NN:
M])<Z[XBO[CQ_9_VR_P!DL)M9M['3='CTO]]_^"6/_!%O]DC_ ()2?#R/3/@[
MH:^-_C=X@T>TL_BC^T=XRTZU7XD>-+I;>T>_TK1)K9Y8O 7P\?4X9[NP\!:'
M++;2!='N_%NJ>,O$.B0Z_<@'/>$?V3_VJ_VXEM_&7_!2/7K;X4_!&YC2Z\-?
M\$U_@5XVU5/!L>EW!D%A;?M?_&WP[_8OB7]H#4;V*;=JGPB\*/X0_9_TPZ=8
MZ9KOA;XHP>=-'_!-X^_8,_X+"_&;_@L5X\^*/PD_8+^(-CXN^#O[4<&H?!^/
MQ]\(8_!7[)'PY^'7P;\>1V?P9\)V'B#5M.\(_!R;X4>'/ NC>%;;PCI'A#6K
M9O%/A:PN[WPS;:[XAN9-0E_U:Q;$AE.U8T54MX5V>5%Y0_<RQ[((GAD'0JKN
MJ  (>F(C8;0%BE>-/+1"JE8\;-JMY;0)$8VFBW0&3YC:Q!18+:_-D _#CX"?
M\$G_ (K_ !<\5^%OV@O^"OO[0<?[;OQE\/ZD?$/@#]G[1M*G\)_L/_ 778(Y
M[2QU3P;\%UMM*A^*7C.UL)I+?_A9'Q6L;G5DLI/LD>AB_0:XW\HO_!6C]CS_
M (*Q_P#!3O\ X+.>)K>#]AOXK>,/V=/@!XWT?X??"A/'27_P3_9^\2_ [P3J
M-CJGBG6K'XR^+A8^"KB?XFPW6H:IX@\1> )_$7BNPL)]$LO#VE7%_P"%['3G
M_P!) +@#)W$=&(&??H /RQGT]?CW]N&;]K.S_9=^,(_89\/^"-<_:KU;P]-I
M7PK3X@>)+;PMX;TC6-3W6%UXLN+RZTZ\L=7O_"-A>WFL^'M$UBWCTC7-7T_2
M].U>YL+&6ZO8P#_/._X.&?\ @HK^VI)XQL?V -;_ &H=#U#Q'9VUG8?'C]F_
M]A_PS>^!OV8_AU-K-K9CPK\!KSQ7?V]Q\8?VAO&ETMY::CXMDU6\^'_P\\/S
M7'A_0M(^%&H>)QJ5_I7])/\ P0._X(!?!S]C?]F*V^*/[97P9^'7Q5_:N^/^
MFV>O^,]$^)W@GPQ\0=/^"/@Z6!]1\/\ POT33O%>F:[9P>*Y+::;5/BAK%E&
M6U#7KNS\-VUQJ&E>$-.U74?EG_@C1_P;%_$O]G']I>R_;H_X*0?$'P'\6/C%
MX>US4/'WP_\ ACX:O-?\=6MC\3=>GEO+WXI_$WQEK6FZ';:YXKT.ZGN;SP]X
M>L]'\0:.-?DMO%-QK,>HZ9;V,?\ :2UN2005W*Y>)@"K([HT+2EB9!)(D#LD
M8=-O 5N""@!_'%_P50_X-@O!_B;55_:T_P""1VJO^RG^U?X)U4^,='^%/A#Q
M%?\ @+P%XJ\1Z%JC:G!J?PD\26>IZ??? ?XA:9.RW_AFW\-W6F_#>YEL++3U
MTOP;:/)K">"?L.?\'#%_XRB\:?\ !,3_ (+DZ=\2?V5_C8VFZC\*=3_:7\/Z
MOK_P$UR/4H&:2.]^)5YX1N_#>L_!OQ/:VZP3Z'\7/A_?6W@;Q/;NE[=6NF:=
M(-0N_P"Y5K5B"C,)(V0(Z/AEDBC!$<4PG2Y:;S SK/-O1V&TA2>GY+?\%3/^
M",7[)'_!5KX=/HWQBT0^!OC/H>EW-E\./VBO VG6,7Q%\(2"22>PTS7OM(6#
MXB^ Q<,DNI^!?%-P]L#Y]WX1U?P7KTPU^( _AI_X.=_V6Y_V*XOV-_A]X)_:
MU_;N_:@^%OQHT#XH_$Z;7OVK?VE=>^.OA"[U/P[=>"=+\)_\(%;QZ)X7\%V:
MZ%HWC+Q+>7.K0Z==76K^'_&VFVYGM[%K._NOZ&O^"0O_  5$_P""'_[#_P#P
M34_9X:Z_:'^ _P *OBY%\)="7]H&SL_!FJGX\>+OB];PW&I^-4\::-X/\$:A
M\1O&UQ_PE&IZM!X:U.[LO$$E_H0TI;"]9;>.V@_F?^/_ ,._VTO^"+6I>&?V
M1_\ @IY^S1X?_;__ ."9UUXJN9_A,_B.\\6VWAO1L7EU*^J_LT?'70KK3OB#
M^RY\4=8T875SXC^&4^L6=E+'J6JZPOAW4;A=)\86G]2__!'W]E'_ (-KOVI]
M"L/B]^PY^SE\(/$WQ+T2S34/%GPK_:#U;QC\4?BW\+)Y&$:PZS\-/C-X\^(-
M@MOM@*:/XR\)1^*?#$4R;=(\2WTT<BJ >CVW_!0S]O[_ (*T[O"/_!*_X/>)
M_P!E+]E?6I)K'QC_ ,%*_P!IWP>MOKFJ:*T1.JS_ ++?P/:6\G\<>((874^$
MO&&MSI86]PNR2U\'W=MYH\M_:C_:._9X_P"#:CP'I\7PV_8Z_:>_;(^._P"T
MA9P^)/BI^U]XYU2?5)OC=\3(]<FTN_TGXX_M-ZZ/'&NZ9XIDF>36O#_PM\.>
M!)/"FE6-S-J5LLGB#7=4U(?U2PVEK:Q6^G6XL[2W@A@AT[3;7R+>."QLDV1_
M9[2TBMEDLA&%4Z>D4EL@ 6.15"HCFN$VRI(\[2K!(2L*W<K20Q1*DDL%NFZX
M.V.9)V6SEFOA++#:272W,D$,P!_ ;^RU_P %,O\ @M__ ,%]?B1XQ^%_[,G[
M3'[(O_!.[X>^&C(WBK2O"6JZ;>_'_4O"\:QQ2ZOH6D^(G\<_%_Q:-.GD%O=>
M*/"=I\'?!EO<R0V%WXDMKO-K-^ /_!<S]C#5OV5/V_/ _P"S#+^U;\9OVW/C
M/K'PJ^&.M?$[XI?&#4[_ %/Q%>?%;XJ>(?$T5MX3\/V%_K?CW5M-TK5/",G@
MC7[)+[Q#XCU:2\\1/*+9;.&">7_10_X*;_\ !"S]F#_@H8S_ !6\,7=]^RQ^
MV3X=E75?A]^U;\%[8>'_ !FFOP1O#;2_$VPTBXT?_A8NF0PN((KB34=%\<:?
M;6\&GZ'XZTC1FN-)E_"+]A#_ (-8?VN/"O\ P4'\*?MD_P#!1[]J_P"'O[1V
ME_#/Q]X?^*=E/I_C'XO_ !9^*OQK\;>!O(M/ K_%?Q-\6O"?A:\TW2=%AT?P
MSJS6R^)_B 3#I*^"%5]%)UB4 _KL_9*_9-^"W[(WP:\"?"WX0_"WX<_#F'1_
M"'A?0/$]_P" _ WAWP9J'C+6="\/:=HUYXG\276@65A>:OK^L7%B^I7FLZC<
M37TDT@9]TA\U?J<12; C." N,_.RN3W=)&:4 =@+DYZGT$FPYR6W$9V@@ #Z
MX!R?>I* *PADVD>9G@C$B1O&X/4R1QQV^3CL' ]<]#9HHH **** "JAMV)C8
ME"T6_P O>L<C)E<#RI3$#%G@.=DA*C HHH MT444 %%%% !1110!!Y3=]CX?
MY=P(6./  "(,KN &,\9SDGC%3T44 %%%% !55H"X*D_N\<PCRV@FXY$B2PRM
M$A;^&)^!SR:** &O;LR@*44["HC<N]M$,<+]GC^SK.G;$K*5&"I_A-RBB@ H
MHHH \K^*OP6^&/QR\ >+/A3\8? _A7XE?#+QO8R:=XI\ ^,M%M-=\*ZS;R^4
M[?:]*O5E7S%N8ENXGMY;?R;D?:H5CU M?M_$/^WC_P &J?C/]GWQG=_M>?\
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D7H)10!^@=-.[*X( S\V>X]!^-%% #J*** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm257951d1_ex5-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257951d1_ex5-1img002.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !V .<# 2(  A$! Q$!_\0
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MB+P=I'A^YG-A<\9_\$\;[XM6/Q)N/C1^T9XV\>^+_'?AGP/X%T37].\$>!?
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M-X/U#Q'!XD.H:;)X8_X)_P#C;PS?PZ\G[7WQ8M_%V@?!?2_@E\./$'A#X>?
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MK#0/&%YX%OOB7X;\2'PO:^/++2-&E\6:%X@L/'>A27=M=R:)8:+]N=8E^_\
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MXE\::HGB[3U*:U=^.?$[>)-(UVWGTDV/&> _^"?NK?!BQT*3X'?M,_$;X?\
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M^>_!OQ9L-)^/WAKQ9I_[:^B_\%2]7TOX ?'^W.D?">T^$R>./V<='TGP%?\
MC6\\2^&-0_9_*>#$U#XH:KX0\/?"40_$CPYXB\=Q:KK>F0>&/%B:)!XO\-^*
MTW)*\5=_=Z]4)-.Z3\UO_7Y>1_09)<0.%<!X&>6Y+74<D :WNO+GM;B*2>28
MZ?--I\ \RYC0:I!!_9=X)+=Y+6!J2/[.4FGA41/(LFZ5+D!I"+25K<>=#]K*
MRQ6,LDUNNF_:HPA:1H8!LC7^67X7Z5XH^/.M^)]'_9C^*?@B[\:^%?V>_ 7[
M47@_2/@=^T-\9/C5X;U_X^_"'XL>'O%'AKP)\:OBEXQU&+2M4\??$KPW=^+O
MA_\ &#>NG^);V#Q#:ZIXG\+K::9::7J/[;_L3_$(_M%Q?%W]K:SDUZ'P+\:?
M$&@>&O@S8ZY_:D=S9?"7X1V>H>&K+4=8T5;Z33--O/$?Q8UWXKZT?[ M+*.Z
M\&'PW=ZUJU[!) 0E*;=I)I>J?IU8-61Y=\>_CM^PQ\2]=U*P_:!^ DOQU\ ?
M!WQ[K_@'7?BUXV_94N?BW\&? 'Q&TO4;3PYXITZ+Q=K_ (.UZRTN;3=9T^_T
M#Q[XC\.V0\'^'K[3]0L/&&L:9#I$^KVWWUX4N_A\;'7/A]X-N=#LXOA;+IGP
MTU;PKX:$VA67A&\E\#^&O$6C>#AI=F]FVG+9^#/%OAO5=$TNP,@T[PYK6C2:
M8!<S02+^0OQ*_:=^%'[/>L?&KQ5^SC\>(?\ A:D/CWXDSZ__ ,$Y/B1X:U_Q
M)XK^(WQAM_&>HZEXJUOX-> O#3V?QQ\"S_%OQ)%=^(-&^)FFZ?\ $?X'1MXJ
ME^)*>#)=;OM9>OD?]K/PM\'?!4_[:7@OP=XA7X8?&3QE^WA^Q"]]H^B?%*]\
M/_%.U^#'C:P_8RT77/$-EO\ $ES<1>'KKXC77Q)L+SQYX7AUN&P\1Z1-H]YJ
M$,7A:T\(6U<_)[W+S=+6OO\ Y%*-W9=NK2VMW:7X^A_3HUU;2J\F^(V\[O$9
MI'5(;EQ/#8/&F74B8L38B65H]T\D,<?F+(B+')+:O<0I(@>:%%$43B!S!$C6
M<US.EI-/'<%X=^G /- ;J"5[5K:WDCN94;^;W]I>'PQ\+/CY\;/A9XUA^#7@
MGP%X7\"_"+PU^RK;_&C]O_X\?LG>--+\&'PA;7&K^)/@AHFB?!;XJ2?%;QOJ
M/Q8U#Q;I&MWVA^,=4\8W]MX4\,>%?$GA?3&L_"K^*>(^+?COXB/K_P 2M(_:
M5\1_!K3/C$WPY^!R? GQ#XX_;3_:\_93\8:/)_PS/X+?7O'_ .RO\ -!_95\
M7>(/B'KB?'W4?BEJ&IFSTJ3XKW]_IEEX/^(OPW\/:/X<\/:EK1[;G]WV?+UY
MK6V_S!P:5]+:;-7UVT3?STT_ _I8LO%?A#6?$.M>#-'UFUD\6>'=/T.76])C
MFGL=;TRSU^&>^T-=0DEM)-1@DO-.TF>X=)W$PBCMOM<2_;8&)7Y+? FU_9Y^
M'/[5OQUOOC7XK^'/@GXU>./@Y^SMXSU&VUCXDZEX+7Q==Z_HGB+_ (6EXP\*
M:!X^U/P/?3Z%/\0M*:.>67P[HVK:7J%W=VVIZ/IIO88YB@FWG]ZN?M;7/>*/
M%6@>#=$U/Q%XGUC2?#VA:/IUYJFJZYK^I6NCZ%I-A8QB2YO]8U:\=;?3--ME
M97N]0N/]'M(=TLK!5P>AKX^_;;^%_ASXQ_!VP\!>(/&G@7P==7OQ0^#^M^"X
MOB79Z'K/@?QIX^\&_$SPQXS\+?#KQ%X5US6O#\7B_3?'E_X?3PM>>'K+6++5
M;NUU6<Z9'J5RHTZ;6HY*-XJ[NO+UZHS2OHCUGX5_M$?!#XYVU[??!3XN?"[X
MPZ?I5Q;6FL:A\*_B#X7^(-CH]S>1AK:/4;WPMJ.IV<!:19(Y%%PTL(,$DD02
M9S#W?B3QMX<\(6-MJGB?6M&T/3;K6/"_AV*]U+5K2SAF\0^-O$.C>#O!WA^U
M-P8C<ZUXK\8>(_#WAGPY8*%DU;5]9L+&V)O;NTM;G\=/VH/VE->_9WTOXC>*
M)?AE\-_A[^UCH/P9^'6M>$_'?@W6+SQM\.?&GP+C_:1^$GPZ\7+=G6]%\"Z]
MH5_X17X@+*=!UG1M3AT2VUZ3_A%_%GB\:+KMEI7T/^T-^T1X\\ _&T_#GPUJ
M&C_V+:Z-^P[/<Z;J.F6U[</9?M(?MM:%^S_XYU&40W#[[?\ X5M'K%GI=T8;
MR+1M0L[W4;D2:9)>+=<_/5_E?WK_ .2'R_S62[O7\KGZ0KJ"M%%(%21Y?DCA
MBF023S!%D:.U-T+6.<(@G=V+QNBPL'C642Q0S-= $A54_-Y:R-+&L)D*HR(S
M(9)(R^\J-T.=Z[<$/$7_  0UCXI_M"_L\ZI^UG<>%/B#>?$+Q?\ %C_@H-X:
M^#>CRP?!S1O&3^!3J/[+/PD^(&H^/I/!NC>,?"^H^.9H/!?ANP^&N@^'+W7M
M-TQ/%G]GW3"P6Z?0HONW]D'XP?&GQCKOQB\$?%K2/%YMOA[-X2\0^!_'/COX
M7V/P5\3:EH_C^+Q>DOAKQ+X%MO%?B>UFC\ 76A27C>*]/71=%U31O$NAVVFZ
M3)?Z!XE>WN$Y\WOII6>M[Z]-F_R#DBOA:;\DUIUW2/M;Q!\1?!?A?Q!X1\):
M]XI\,Z+XL^(5SK5C\/\ PUK?B/1])UOQM?>'M&N_$.MVGA;2;R[35?$$VCZ'
M8W.M:M#HEAJ5UI^CPRZE/;"U@G>/B8_VC/@=<?$^\^"-K\7/A;/\:+"TNKZ]
M^#\/Q&\'77Q4L[*&UAU""_O/AUIVKW_C.UT^[TF=-=6[ET0+;:&1J5XL"90?
MBAXS_:7^"OB3]L;]GCX^^/\ Q9JF@:CX5_:9\>?"_P &>$=<\'^-QJGPZ^ W
M@+]E;]L'POKVNSK%X6>U?7?CE\9;[0M8\3V6EZIK+7G@#P]\'(-2T_3=5\,Z
MQ)9[?A_2M /[)/P0\4,KM\8[K_@KA;7.K3K:6=YXCF^*VM?\%!_&_P /_C#:
MS,+:ZE2^L?@A?_$"S-QKRRP67P]T2TU$36=N;2=KG/W?<U=UY:==[?F5&&OO
MZ+77SZ;'[)1?M&_!&;XGW7P/A^+'POF^-ME:3W]W\'8OB-X./Q2@L8-/CU07
MTO@"75X?%L=C/ICOK$-_)HZ6*Z%%+JES<VZ(T(DL_P!HGX(ZA\3I/@I8?%GX
M87WQBMK-M2O/A1:_$#PM-\2X--CM)KN6_3P&NH_\)3/9QQ6\]RMXNE+83Z?9
MZA>6]Y*UA<6Z_C9X6TSP_+^RC\$/&L+6D/Q?U7_@K;;ZEJ$^C6CVNJS?$KQ+
M_P % _'/@/XP:?%%IL6^PEM/@'/XSTBXQ=P6FE^"=#@N;?4D@M(KRX/"UKX8
M;]EGX'^/(4L/^%W:K_P5JL?$6KZA9VFEQ>(YOB5XC_X*$>(?!'Q:TRXO)TAN
MIX]-^ D/CGP[=6T5]-)#\.O"^F)/>W%K9PZE=Q"<^;WTTK/K?7ILW^14X02?
M*[NZTU^>Z1^]\=Z) I$4@#I+('*2JBJOD-"K"2*.5I9H[A,QQ12^7.DUL6:2
M%J\+U']JC]G;2OB/;?!N_P#CE\%K/XO7D\5I9_"V\^+GP^MOB'>7<UP;%(;3
MP4^OGQ3<%=3CNM.EA31_[0:ZM+B.TL+QHG5?94@:.RQ!+]I61?/"!T+3K]FV
M)()TA@FN)[J:);H3M-#<&>6:5+J:*&* _D!^S-\.OV7_ (C_ /!,?1+;]J ^
M X_!?C6SU/QE^UIK?C7Q8?A]#IOQX/CC5+OXDZAXR\>6&N>%M8\$^+_#'Q62
M;PVNMWOB?0/$>GIH^GZ&NOSZ?I]E%)<Y^[[FKNM-M.N]OS,K/L?L;%J$<P/E
MHS,I",,K&!*#")(AYQB;>AG0,KI&ROO@D6.X1X59!J44X1E7Y9-GER!B(9Q+
M&\L/V6:5(4N'*Q2)+"G^D6\R8EA$3+.?Q9^(O[7'QZ\"_!KXU_M>:!X]^&US
M\$_V>?C?K_PPL_V<KOPZ;SQ7\0/A[\*?B9#\)->9OBY>>,+NXM?BM\4;Z;3/
M'?P72W\+75AJ&D:Q\-O#V_Q5>^.+KQG,NN?'3]N.ZT#Q?\6O"WQ5^#5EIMM^
MW-JO[)OA3X7^+/@_K^HZ6WA?Q'^T!-^SKX5\7^*O$N@>/=,\6_\ "4^&]?U#
MP]XOCM+./PCI>O:-X=CTW4;S0=5\4ZC=^'L>>K_*_O7_ ,D-0OH[)>?],_:O
M[;'\^<#;C"_.SMM ,ZH(XW69X/F61;9YPKJ4D>,YPS^T8"(V5HG25XHHF6XA
M.^:23RS$C;Q#)(H!?9%+))M4AD0E _XD?M'?M,_M@?LY6OQ1^&UM\1/AY\0O
MB7I7C;]@A_AU\1M0^$L_A_2TT#]K7XZ>+O@WXD\/:YX5TCQI=)KEMX5O?A5X
MAUZ'5]/UVSU;[%XSL;'6(]0BT-;C4_8=%N?VZ?$?Q=^,OP)L_P!IOX6)+\)_
MA?\ #?XC:'\2(O@!IMUKOB76OC$/B9X?\->#O$F@CXDQ^&;/PAX<\2?!G7=4
MUF_TN6P\0>*]/\7:!HXO_#4_AR]U+4+A.?-[Z:5GK>^O39O\ANFDKIIOR5OT
M1^K0NB5W>3)@EL* 1(RQ@>:5C=48F-R4"$"20(SQHR[=U2YD$R*LR^7!*RPM
MNDBV2"7:$+I<3P Q;93#<6LUK)++)($6)ECC>3\%-*_;L_:H^/$*>(?A1I/B
M/P+::?\ !+]F[QW;V'A+]G%?C=X?\5^//BS\#_"?QOUB/Q5XJF^+?@Y-*\(:
M>WCK0_ >EZ=H!GOM,U"VO=1U#6KE#HVDZAU.O_MO_M%:)X&_:I_:4U>+PU#X
M#^!O@7]G>]\._ !/"5I=WC^.?V@?@=\(O&.HS_$CXJQ:W>1Q_"[X2^-/BS#K
M>MZCI6@I?Z5H>A^+-7NK^;2UT?3[G24DU9/JNX*+OJOR/VVDMTE)9VQ KW"L
M\BF6)G%O-:W+3L6V_9K0S2PP0W$$=E@72S60S:WD2B""XC2Y_?>5)'+-(5N
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M!=?\=_%[QUXV\:7'@[1(M8U$Z#X6M->LM T:1K*YT_38+W3K>Z$?@3_@G?\
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MU*W\9\3_ /!.O5/&%M'XLU[]H;Q7>_'J7X]_"3X[7WQBG^'GP^D$=S\$=/\
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2GUYEL2BBF*U^KV6S_P" ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm257951d1_ex5-1img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257951d1_ex5-1img003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  6 B$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#UB:&_@N)=
M\^HFS:\*N8R6=8_+!7;@9QO)!(Y_"J>[Q,"9<7 )@V]B=VS/W<8#=3G/WAMQ
M@UV=% ''RR:Y'YTM@;V6VA$C11S)B28;%^7YAG(8L5SU((Z4\Q:K&S223:@8
M6,'F[22RH5)<H ,YW;0<<@9Q76T4 4-'-RVG(;KS-^]]AE&'*;CL+#UVXS5^
MBB@ HHHH **** ,W6FN%LX_(,X0RJ)F@7,@C[E1U].G.,XK%N;G6X[B=[>&[
M-@(1%"Q&9-RX;>5(W<C<OX#CFNLHH YBXU"^CU)ITM;^=2P\B)59$\OR^I&W
MEM^00Q!'&*IH?$NZTBN!<!H"1/)&V0P+H0PPN&PI88XQ@GK79T4 9NC)?K!,
M=0E9Y!*T:97 V*=H;ZMC<?KQ6E110 4444 %%%% %745N&T^?[(Y2X"[HR.[
M#D#\<8_&N=%UX@>:&?[-<+ R,TL9QN0R9V*!CDH F<>K=:ZRB@#D(Y=:'EP:
M@;T01^6DUQ;Q_-(-C'< HR.=H;'0CT-/EDU<2SF W[7 :;<K)^[\H ^65)&-
MQ^7WR6S7644 <S)-J\]]OMA="TNI_*4M'M,* (Q?!&0#B1>>Y6L^)O$#6]@Z
MM=[U#-<YW@J=T?\ "R_-P7^4<=<'BNVHH **** "BBB@ HHHH YK77UQ+^==
M.\XPS6@B0HH(BE.\^8/< 8QZE:ISOK;03^4VH+?%9 RA/W:Q[#L*<8WYV^^<
MY&*[&B@#F88]7N;M1=O=Q>5=K$QB;:DB"+)<8_A+8^A)%9<"ZZXT]-1%V8S*
MLDPPSC[@()*KD'?GY<8!'7D5W5% '+V=]K,5XK:A;7*P27!E78GF;8V1P$(4
M9&"$/X]:ZBBB@ HHHH **** "N>UQ]26\?[,;L8@4V@@7*--N.1)QTQMZX&-
MW>NAHH YIK"_WN1=:CC[>%'[T_ZG R?IG/-4WF\32";$4\)GF!A(PWE1R IR
M,<%/D?!SU:NQHH Y*&[\1F6TF>UG\M)2URAP,ID1@ 8Y^ZTG'JOTKK:** "B
MBB@ HJO<WUK9;/M-Q%#O.%\Q@,TX7=N8!,)5,9;:&SQG=MQ^?% $U<]J,FLQ
M:NS6PFDM'DMXBBJ/W8WY9QZC&0WU![&NAJ"*]M9[B6"*XC>6+AT5LE?K0!R4
M;>(?L-H(7NC+*&\XLC?NV3#_ ,8'WL%../FXK<7^TG\-";+IJ)0W C8<AL[Q
M&1Z?P5L9'K48GB,[0"1?-50Y7/(4D@'\2#^5 ',M_:\5R%,M[)<AH_+PG[EH
MRH,A;C&0=^,\\+BJ=H_B:-+19A<E!S=#[SA"L7W"0,MDOQV^8#/%=@MW;O=/
M:K/&;A!N:,,-P'J1^(_,4V&^M;B>2"&XCDEB^^JL"5^M %BBBF)-'*SA'#%&
MV,!V. <?D10 ^BF/+'%M\QU7<P5=QQDGH/K4$^HV5LBO/=PQJSE SN "PZCZ
MC!_*@"U13'FCC,8=PID;:F?XC@G'Y U&][;1W)MGF03"(S%">0F<;OIF@#+U
M:YU"*XNXK19RSVBF I%N4."V[G& V,8!/I68\FLQEI; WLUK"7=(YTP\R[%R
MOS $'))7/<$=*Z3^T;/[+!=?:8_(N"@B?/#[\;<?7(Q5G(]: ..\W7]LY@^W
M&Y^;<LD>(PGEK@KD8W[LX [YS3I9-<C:66P-[+:PK(\<<R8>8;%^7YAD'<6*
MYZD$=*[#-&: .-\SQ%ZW7_?O_P"M17944 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1KFC2:N(1'.(
MMBNC$[NC #/!&<8Z'(/<5F2^$)IY?FU)D0(5#11[7 +!NOL1D>YHHH MZ7H-
MQI>H/<BXCE\W"OPRX7'0#.."!CT!-1W/AV[FTR334O85M?,=T)AR^&+'DYZ@
MMD$8SCFBB@"%O"<Q8[+Q(LR.P=8R64,,'!)Y)ZY/([4R'P>\!B=+J,2(4.2A
M8+M9B2 3CG=T/ ZBBB@"]'H-S%XDDU5+X!)&_>1^7RZ[<!<YP ",\ 9XSG J
M-/#4WFP1RWBO90.&2'8</ARPW#.,\XSCGO110!F'P[*NI)8O?-YER'FG>-=@
M* *  ,]=^UNW<5;'A&3DBY@BW-G$,)41?=YC^;@G;@GN#110!<7P\]O8B"TF
MB1DN(IT#1G:"BJ#D ]RI/XTA\/27+(E[.CVZS2R[(@R%Q)NW*QST^;\J** -
M#4(\S:;MP ER#CV\MQ6/X@\)-K>M6U^MXL'E1K&1Y6YQAP^5;(P3C:>#P311
M0!C_ /"N+AW&_7)$0110@P1>6X5#&00<]1L.#C/S4Z3X=2R)=;M24O-&BJ0C
M*L979T4-@@; 0#GJ>U%% %_4/!]UJ,LCRZA 2UL+<,;<YC"L2-N&P P.''<#
MC%4_^%<1RJ/M%XDI P!Y1VH-LHVJ-W"@RJ0/^F8_ HH L_\ "&7W_0=G_)O_
( (JBBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm257951d1_s3asrimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257951d1_s3asrimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !8 2<# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M445%<W,-G;/<7#[(D&6;!./RH J:E:S-#+<Z>L:ZCY8C21@/N[@2.>/6F6FI
M)$;:QU"YC&I.@+(O<_4<9J^EQ#(X1)4+E0^W/.WUQZ5EW^C67VYM9=)GGA7S
M-B'ABHXXQUXH!*^@:^LD-NE]:V*7-Y$P"$H6*@]3@=?_ *]2S7Z1>&Y;[5X?
M)C6W9[B/KA<'(_$=O?%<IX(\=ZAXOFU.VDL8K:6&/?#(F2HSP V>^>??GBJ?
MAJ'Q#I-CKMQXYG=]*,1#+/*)=V>#M )P"#C''48%3S=CTWE\Z<I1JM*4>7W;
MZN_;S-WP'XBT;7K*Z72;26T,#@RQ2').[.TYR<]#],5=$]U>^)?LUUIBFVMV
M+Q3E&RI'0YZ<_P">E<AX;N-(O?"FM6G@..>TU0J&(N6 D;G@ALD=-P'/!/OF
MKNDWWB;PI\.]0U#7E>ZO8'W01S2>8X4E5^9@3D9)/7./T2EW-,3@8^TDJ7N^
M\DHR^+7KZ';7FJV.GR1QW5PL;R?=!!/\NGXU<K@O"M]%\0]+-_JEDT%Q;2>5
MNA8B.08SQG/KS^'-=[5)WU/-K49T*DJ4]T%%%9UYK^CZ>YCN]4LX)!U1YE##
M\,YIF1HT5GVFNZ3?N$M-3LYW/18YE+?EG-:% !1110 45#=74%C:2W5S(L4$
M2EW=N@ J+3=3L]7L8[VPG6:WDSM< CH<'@\C\: +=%%% !1110 4444 %%%4
M]3U6QT:R:\U"X6"W4@%R">3T  Y- %RBH;2[@OK2*ZM95E@E4,CKT(J:@ HH
MHH **** "BBB@ HHHH **** "BF3.\<$CQQ^8ZJ2J9QN..!FLV[U#4(9;$0Z
M8\BS8\[G/E].,CC\3Q0!-<:7&]Q<7D!,=[) 8EDSPOH<?E7-ZKJFJ^"_!]Q?
M7(%_<B8!0SLRH#QDGKC_ !K<_M.^_P"$E_L_['_HFS=YV#Z9SGIC/%<;!XN\
M27/Q'ET.?2U;3/.:)D:$\1<XD+=.1@^G.*3=CMP5!U9N=DU#5INUTNA2U[4M
M<\2?#2VU+2+&2UDGN&:\CM%.Z0#(W#')!(&>_P" -:'@#1]2U/P1?:=XECN3
M:W+E84G)$@3 .1GD#/(S61J7CCQ/9?$?^Q[:)19I<+#'9"%?GCX^8'&1D<]<
M"O7:A:NYZ>,J5,-AXTE"*4WSIIW:UT5_+O\ (Y+0/ ]MX2T_43I$LLNH7$3!
M)9R." =HQC&,XS7!_#ZS\6KXU/\ :,6H"TQ(+W[4&V-E3@?-P3N(Z=O:O::*
MKE..&9U%&JJB4G-6N]UZ#(HHX(UCBC6.->BH, ?A3Z**H\L\\\>>)K]M2A\+
MZ$S"^N,"9T.&7=T4'MQR3V%6M%^%^B65JIU-#?W9Y=V=E0'O@ C(^OZ5A^#5
M%[\6-=N)^983.4!ZC]X$_1>/QKU6F(X+6_A9I%U TFD;[&[490!RR,??.2/J
M#QZ5TOABWU>UT&"'6YUFO5R&8')VYX!/<X[UL5B>+=</A[PW=7Z &8 )"#TW
MMP/RZ_A2&2ZMXGT70V":CJ$4,A&1'RS8]=J@FETKQ)H^N$KIVH13N!DH,JV/
M7:<&N&\%>&=)NK$:WX@F@O+Z[)D"7$@(4'N0>I/7GVJ#QOX>TS2;>/7_  Y/
M%:75K(I>."48()QN SP02,@<8S3$=KXY_P"1)U;_ *X?U%9GPN_Y$B#_ *[2
M?SHUC51K?PJN=2 "F>TRP'0,#AA^8-1?#>XCM/A\+F4D1PO-(Y'H#DT =3JF
MMZ9HL0DU&]BMPWW0YY;Z <FJ.G>,_#NJW"V]GJD+S,<*CAHRQ]!N R?I7"^%
M],L?%^HWOB/Q%-$ZR2E(+5YL!0/7G.!D #ZUL>*?"/AN[TBXGTT6EI?0(9(F
M@D"AB!G:0#CG'7KF@9W]8VJ>*]"T:?R+_4H8IN\8R[#ZA02/QK-\%Z]=:]X-
M^TG]Y?P!X&+='D4 J3]05S^-<#X'_P"$:GNKU?%&UM4DF.#>Y"8[Y)XW9SG/
MMBBP'J^F>(-)UG(T_4(+AAR45OF ]=IYKD/BIJ]K'X?;2UNU%X\B.T*DY*<]
M?;(%:UKX#\/PZQ:ZQIZR0M$=Z+#+F-SCKSG]"*QOBOI5B="_M3[,GVT2I%YP
MSG;SQZ4"+WAKQIH-OX;TRWN]7B6Y2W1'#YR"!C!.*Z+7FT<Z/(VM^0;#*EC+
MR,YXQCG/TKF?#'@GPY>^&M,N[G2XY)Y8$=W+M\QQUQG%/^*@"^"BJ@ "XC
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M '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45954121758976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001030894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">CELESTICA INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3ASR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45954119571040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Mar. 03, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common shares, without par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">An indeterminate aggregate initial offering price or principal amount or number of securities of each identified class is being registered as may from time to time be offered at indeterminate prices and as may from time to time be issued upon conversion, redemption, exchange, exercise or settlement of any securities registered hereunder, including under any applicable anti-dilution provisions.

In accordance with Rules 456(b) and 457(r) under the Securities Act, the Registrant is deferring payments of all of the registration fees (except with respect to the carry forward securities identified in the "Carry Forward Securities" table above and footnote 5 below, with respect to which registration fees have already been paid). Any subsequent registration fees will be paid on a pay-as-you-go basis based on the fee rate in effect on the date of such fee payment.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred shares, without par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">See footnote 1.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">See footnote 1.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants to purchase common shares, preferred shares, debt securities or other securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">See footnote 1.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">	 Common shares, without par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 643,337,715.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-273467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jul. 27,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 162,027.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 415(a)(6) of the Securities Act, this Registration Statement includes and carries forward $2,573,350,863.72 of unsold common shares, preferred shares, debt securities and warrants to purchase common shares, preferred shares, debt securities or other securities ("Unsold Securities") that were previously registered by the Registrant pursuant to its registration statement on Form F-3 (File No. 333-273467) with the Securities and Exchange Commission on July 27, 2023 (the "2023 Registration Statement"); filing fees of $648,111.04 have already been paid with respect to such unsold securities ("Unutilized Fees"). In accordance with Rule 415(a)(6) of the Securities Act, the Unutilized Fees will continue to be applied to such Unsold Securities and are being carried forward to this Registration Statement. The effectiveness of this Registration Statement will be deemed to terminate the 2023 Registration Statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred shares, without par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 643,337,715.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-273467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jul. 27,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 162,027.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">See footnote 5.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 643,337,715.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-273467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jul. 27,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 162,027.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">See footnote 5.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants to purchase common shares, preferred shares, debt securities or other securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 643,337,715.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-273467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Jul. 27,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 162,027.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">See footnote 5.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdFormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., "Form S-3" in the human-readable and "S-3ASR" in the XBRL).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdFormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:formTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrevslyPdFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrevslyPdFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFctvDt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFctvDt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule415a6Flg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is claiming a 415(a)(6) carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule415a6Flg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45954119813504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 03, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,573,350,863.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MQ=(<+AB=,:%O@,_U\QY/]&^SMC^MN_H?4$L#!!0    ( %J(8UKWX[??. (
M ,T%   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULC51M;YLP$/XK%INF
M39H"@0!1!DA-JVJ5]A(UZ_9AV@>''(E5@YEM0OOO=S8$91*)\@7[;#\O9W.7
MM$(^JSV )B\EKU3J[+6N%ZZK\CV45$U$#17N%$*65&,H=ZZJ)="M!97<]3TO
M<DO**B=+[-I*9HEH-&<5K"1135E2^;H$+MK4F3K'A4>VVVNSX&9)37>P!OU4
MKR1&[L"R9254BHF*2"A2YV:Z6,;FO#WPDT&K3N;$9+(1XMD$#]O4\8PAX)!K
MPT!Q., M<&Z(T,;?GM,9) WP='YDO[>Y8RX;JN!6\%]LJ_>I,W?(%@K:</TH
MVL_0YQ,:OEQP9;^D[<[ZD4/R1FE1]F!T4+*J&^E+?P^G /\,P.\!OO7="5F7
M=U33+)&B)=*<1C8SL:E:-)ICE7F4M9:XRQ"GLWL 1=;=BR2N1D:S[N8]>MFA
M_3/HKU1.B!=\)+[GA^1I?4?>O_WP/XV+A@97_N#*M[S!%:[([R^X2QXTE.K/
MF,6.:C9.97[JA:II#JF#?ZT">0 G>_=F&GF?+A@-!J/!)?;LA]"4D^]% 9)5
MNS%W'3ZR>%,AA\P/XR (O7D43&(_<0\C\K-!?G91?B7AP$2C^"M94;8E-Z5H
M*CUFH^.)3VQXX]+A(!U>D3D^U 71\%K1:!"-KKMNA>WJO&YTK6X\Z,87=;^A
M'*8ZIM4!YQ>TW)/J-(T.BV;'*D4X%(CQ)C%>D^R:1Q=H4=N"W0B-Y6^G>^RW
M(,T!W"^$T,? ]("A@V?_ %!+ P04    " !:B&-:E^/F71$#  !Q$   #0
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M4$L! A0#%     @ 6HAC6O^?L87N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 6HAC6IE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !:B&-:+\,UR48"   M!@  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 6HAC6N7Y68V0"0  9C<
M !@              ("!B0H  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+
M 0(4 Q0    ( %J(8UKWX[??. (  ,T%   8              " @4\4  !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !:B&-:E^/F71$#
M  !Q$   #0              @ &]%@  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( %J(8UJ7BKL<P    !,"   +              "  ?D9  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( %J(8UI2<6^U70$  $@#   /              "
M >(:  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !:B&-:NVSJ[+H    :
M P  &@              @ %L'   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " !:B&-:IOQ*6R,!  #?!   $P              @ %>
L'0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "P + ,H"  "R'@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm257951d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm257951d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tm257951d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="tm257951d1_ex-filingfees.htm">tm257951d1_ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="69">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm257951d1_ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "tm257951d1_ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/ffd/2024q2": 3,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 9,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 69,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm257951d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm257951d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm257951d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm257951d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001104659-25-019842-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-019842-xbrl.zip
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M7XII6@G<XP1N\_" F_XM@Z8?(7"+ETK/:_%RZGEMP(=NY_]02P$"% ,4
M" !:B&-:.Y'I28 .  "FEP  '               @ $     =&TR-3<Y-3%D
I,5]E>"UF:6QI;F=F965S+FAT;5!+!08      0 ! $H   "Z#@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>tm257951d1_ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="offrl_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001030894</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-365">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-366">S-3ASR</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-367">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-368">0001030894</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-369">CELESTICA INC</dei:EntityRegistrantName>
    <ffd:FormTp contextRef="rc" id="ixv-457">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-458">CELESTICA INC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-459">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-460">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-461">Common shares, without par value</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-462">true</ffd:Rule457rFlg>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-463"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:PrevslyPdFlg contextRef="offrl_2" id="ixv-464">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-465">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-466">Preferred shares, without par value</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_2" id="ixv-467">true</ffd:Rule457rFlg>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-468"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:PrevslyPdFlg contextRef="offrl_3" id="ixv-469">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-470">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-471">Debt securities</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_3" id="ixv-472">true</ffd:Rule457rFlg>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="INF"
      id="ixv-473"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:PrevslyPdFlg contextRef="offrl_4" id="ixv-474">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-475">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-476">Warrants to purchase common shares, preferred shares, debt securities or other securities</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_4" id="ixv-477">true</ffd:Rule457rFlg>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="INF"
      id="ixv-478"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:OfferingSctyTp contextRef="offrl_5" id="ixv-479">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_5" id="ixv-480">  Common shares, without par value</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_5" id="ixv-481">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-482"
      unitRef="USD">643337715.93</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="offrl_5" id="ixv-483">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_5" id="ixv-484">333-273467</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_5" id="ixv-485">2023-07-27</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-486"
      unitRef="USD">162027.76</ffd:CfwdPrevslyPdFee>
    <ffd:OfferingSctyTp contextRef="offrl_6" id="ixv-487">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_6" id="ixv-488">Preferred shares, without par value</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_6" id="ixv-489">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_6"
      decimals="INF"
      id="ixv-490"
      unitRef="USD">643337715.93</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="offrl_6" id="ixv-491">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_6" id="ixv-492">333-273467</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_6" id="ixv-493">2023-07-27</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="offrl_6"
      decimals="INF"
      id="ixv-494"
      unitRef="USD">162027.76</ffd:CfwdPrevslyPdFee>
    <ffd:OfferingSctyTp contextRef="offrl_7" id="ixv-495">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_7" id="ixv-496">Debt securities</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_7" id="ixv-497">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_7"
      decimals="INF"
      id="ixv-498"
      unitRef="USD">643337715.93</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="offrl_7" id="ixv-499">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_7" id="ixv-500">333-273467</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_7" id="ixv-501">2023-07-27</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="offrl_7"
      decimals="INF"
      id="ixv-502"
      unitRef="USD">162027.76</ffd:CfwdPrevslyPdFee>
    <ffd:OfferingSctyTp contextRef="offrl_8" id="ixv-503">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_8" id="ixv-504">Warrants to purchase common shares, preferred shares, debt securities or other securities</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_8" id="ixv-505">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_8"
      decimals="INF"
      id="ixv-506"
      unitRef="USD">643337715.93</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="offrl_8" id="ixv-507">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_8" id="ixv-508">333-273467</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_8" id="ixv-509">2023-07-27</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="offrl_8"
      decimals="INF"
      id="ixv-510"
      unitRef="USD">162027.76</ffd:CfwdPrevslyPdFee>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-511" unitRef="USD">2573350863.72</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-512" unitRef="USD">0.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-513" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-514" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-515" unitRef="USD">0.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-516">An indeterminate aggregate initial offering price or principal amount or number of securities of each identified class is being registered as may from time to time be offered at indeterminate prices and as may from time to time be issued upon conversion, redemption, exchange, exercise or settlement of any securities registered hereunder, including under any applicable anti-dilution provisions.

In accordance with Rules 456(b) and 457(r) under the Securities Act, the Registrant is deferring payments of all of the registration fees (except with respect to the carry forward securities identified in the "Carry Forward Securities" table above and footnote 5 below, with respect to which registration fees have already been paid). Any subsequent registration fees will be paid on a pay-as-you-go basis based on the fee rate in effect on the date of such fee payment.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_2" id="ixv-517">See footnote 1.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_3" id="ixv-518">See footnote 1.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_4" id="ixv-519">See footnote 1.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_5" id="ixv-520">Pursuant to Rule 415(a)(6) of the Securities Act, this Registration Statement includes and carries forward $2,573,350,863.72 of unsold common shares, preferred shares, debt securities and warrants to purchase common shares, preferred shares, debt securities or other securities ("Unsold Securities") that were previously registered by the Registrant pursuant to its registration statement on Form F-3 (File No. 333-273467) with the Securities and Exchange Commission on July 27, 2023 (the "2023 Registration Statement"); filing fees of $648,111.04 have already been paid with respect to such unsold securities ("Unutilized Fees"). In accordance with Rule 415(a)(6) of the Securities Act, the Unutilized Fees will continue to be applied to such Unsold Securities and are being carried forward to this Registration Statement. The effectiveness of this Registration Statement will be deemed to terminate the 2023 Registration Statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_6" id="ixv-521">See footnote 5.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_7" id="ixv-522">See footnote 5.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_8" id="ixv-523">See footnote 5.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
